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THE VASCULATURE WITHIN THE PARAVENTRICULAR NUCLEUS OF THE 
HYPOTHALAMUS: INFLUENCE OF DEVELOPMENT, GAMMA-AMINOBUTYRIC ACID 
(GABA) RECEPTORS, AND PRENATAL GLUCOCORTICOIDS 
 
 
The paraventricular nucleus of the hypothalamus (PVN) is a critical brain region that regulates 
many homeostatic and stress responses.  In addition to its dense cytoarchitecture, it also 
contains a vast network of blood vessels.  These blood vessels within the mouse PVN have a 
higher density than other brain regions, which develops postnatally.  Loss of gamma 
aminobutyric acid (GABA) signaling or prenatal dexamethasone (dex) treatment decreased the 
blood vessel density.  Dex also decreased blood brain barrier (BBB) competency while 
increasing desmin-immunoreactive pericytes at postnatal day (P)20.  Long-term consequences 
included a decrease in GFAP contact with blood vessels selectively in dex-treated females, and 
an increase in depression-like behaviors in dex-treated males.   
 
Chapter 2 examines the blood vessel density within the PVN.  Initially the blood vessel density 
is similar than surrounding brain regions, then after P8 there was an increase that resulted in a 
highly vascularized network around P20.  The highest densities were restricted to the rostral 
and mid regions of the PVN, where the neuroendocrine neurons are housed.  In addition, mice 
lacking a functional GABAB receptor had a significant decrease in blood vessel density in the 
mid region at P20.  
 
The protein endocan has been proposed to be a “tip cell” marker, indicating angiogenesis.  To 
further characterize the postnatal angiogenic period within the PVN, recently developed 
antibodies against endocan were used. Chapter 3 provides evidence that endocan is normally 
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expressed in the mouse brain but not restricted to tip cells.  In addition, prior perfusion with 
fluorescein isothiocyanate (FITC) prevents endocan-immunoreactivity (ir) and provides a novel 
method for identifying non-functional blood vessels.   
 
Chapters 4 and 5 show that excess fetal glucocorticoids alters the BBB within the PVN at two 
time points.  At P20, there was a loss of BBB integrity accompanied by an increase in desmin-ir 
pericytes on a reduced blood vessel network due to dex-treatment for both prepubertal males 
and females.  In contrast at P50, the blood vessel density and BBB were no longer disrupted 
following fetal dex-treatment.  However, there was a decrease in glial fibrillary acidic protein 
(GFAP)-ir astrocytes in dex-treated females and an increase in desmin-ir pericytes in dex-
treated males.   
 
In conclusion, the work set forth in this dissertation indicates that the dense vascular network 

















To my family: my parents Suzanne and Thomas, Gma Anna, Aunt Debbie and father Martin.  
Thank you for shaping me into who I am and supporting me along this path.  Cameron and 
Kayla, my “real” friends, thank you for always being there for me and not letting the distance 
allow us to grow apart. 
 
To Drs. Marilyn McGinnis, Augustus Lumia, Rebecca Cunningham, and James Roberts for 
introducing me to the field of research.  I would also like to thank my committee members 
Michael Tamkun, Shane Hentges, and Deborah Garrity for their time and support.  Also, Karen 
Solomon, Nancy Graham, Lori Williams, Erin Bisenius, Shazette Pierce for your help along the 
way.   
 
To my mentor Dr. Stuart Tobet who worked tirelessly to improve my writing and critical thinking 
skills.  I was lucky enough to sit at your lunch table at the Society for Neuroscience annual 
meeting and forever changed my life.  Current and former members of the Tobet Lab, including 
but not limited to, Kristy McClellan, Gabe Knoll, Matthew Stratton, Cheryl Hartshorn, Chad Eitel, 
Pankaj Kumar, Brian Searcy, Chad Eitel, Qian Zhang, Melanie Schow, Connor Nash, Michelle 
Staros, Circe McDonald, and Colleen McCollum.   
 
In no particular order, Reagan Pennock, Philip Fox, Elizabeth Akin, Shawna Matthews, 
Alejandro Trujillo, Christina Dennison, Rebecca Lossing, Krysta Chapin, Mallory Shields, An 
Dang, Albert Gonzales, Sara Neys, Brett Beal, Matthew Dicken, Caitlin Kelly, Krysta Chapin, 








ABSTRACT .................................................................................................................................... ii 
ACKNOWLEDGEMENTS……………………………………………………………………………… . iv 
CHAPTER 1. INTRODUCTION…………………………………………………………………….. .... 1 
     
CHAPTER 2. GABAB RECEPTORS AND THE DEVELOPMENT OF THE PVN  
                     VASCULATURE   .................................................................................................. 13 
                        Overview ............................................................................................................. 13 
                        Introduction ......................................................................................................... 14 
                        Materials and Methods ....................................................................................... 16 
                        Results ................................................................................................................ 18 
                        Discussion .......................................................................................................... 20 
                        References ......................................................................................................... 29 
 
CHAPTER 3. ENDOCAN IMMUNOREACTIVITY IN THE MOUSE BRAIN: METHOD FOR     
                     IDENTIFYING NONFUNCTIONAL BLOOD VESSELS ......................................... 32 
                        Overview ............................................................................................................. 32 
                        Introduction ......................................................................................................... 33 
                        Materials and Methods ....................................................................................... 35 
                        Results ................................................................................................................ 37 
                        Discussion .......................................................................................................... 38 
                        References ......................................................................................................... 46 
  
CHAPTER 4. DEVELOPMENT OF THE BLOOD-BRAIN BARRIER WITHIN THE    
                     PARAVENTRICULAR NUCLEUS OF THE HYPOTHALAMUS: INFLUENCE OF  
                     FETAL GLUCOCORTICOID EXCESS .................................................................. 48 
                        Overview ............................................................................................................. 48 
                        Introduction ......................................................................................................... 49 
                        Materials and Methods ....................................................................................... 51 
                        Results ................................................................................................................ 54 
                        Discussion .......................................................................................................... 58 
                        References ......................................................................................................... 70 
    
CHAPTER 5. PRENATAL DEXAMETHASONE ALTERS THE COMPOSITION OF THE       
                      BLOOD-BRAIN BARRIER WITHIN THE PARAVENTRICULAR NUCLEUS OF  
                      THE HYPOTHAMUS OF ADULT MICE ............................................................... 73  
                        Overview ............................................................................................................. 73 
                        Introduction ......................................................................................................... 74 
                        Materials and Methods ....................................................................................... 77 
                        Results ................................................................................................................ 81 
                        Discussion .......................................................................................................... 83 
                        References ......................................................................................................... 94 
 
CHAPTER 6. DISCUSSION ....................................................................................................... 99 
 
REFERENCES ......................................................................................................................... 108          
 vi 



























LIST OF FIGURES 
 
 
Figure 1.1 Image of blood vessels, pericytes and astrocytic endfeet in the mouse brain ............. 7 
 
Figure 1.2. Proposed model of postnatal blood vessel development along with alterations  
           due to changes during embryonic development .............................................................. 12 
 
Figure 2.1 Blood vessels within the paraventricular nucleus of the hypothalamus (PVN)  
           across development and region ....................................................................................... 25 
 
Figure 2.2. Changes in total length of blood vessels as a function of age, sex,  
           paraventricular nucleus of the hypothalamus (PVN) region and GABAB receptor     
           function ............................................................................................................................ 26  
 
Figure 2.3. Changes in blood vessels density in the paraventricular nucleus of the  
           hypothalamus (PVN) as a function of GABAB receptors .................................................. 27 
 
Figure 2.4. Changes in blood vessel length in the mid region of the paraventricular nucleus  
           of the hypothalamus (PVN) and the cortex (CTX) at the lateral edge of the section  
           as a function of GABAB receptors .................................................................................... 28 
 
Figure 3.1. Immunoreactive endocan was distributed throughout the mouse brain at  
           postnatal day 12 .............................................................................................................. 42  
 
Figure 3.2. Immunoreactive endocan was distributed throughout the brain in C57BL/6J 
            background mice on postnatal day 20 ............................................................................ 43  
 
Figure 3.3. Immunoreactive endocan was distributed throughout the brain in FVB/N but not  
            mixed C57BL/6J /S129/CBA background mice on postnatal day 20 .............................. 44 
 
Figure 3.4. Vascular perfusion of FITC allowed identification of cerebral vasculature, but  
            blocked detection of endocan immunoreactivity ............................................................. 45 
 
Figure 4.1. Postnatal blood-brain barrier development in the mouse cortex (CTX), lateral  
            hypothalamus (LH) and paraventricular nucleus of the hypothalamus (PVN) at P12,  
            P22 and P52 ................................................................................................................... 63 
 
Figure 4.2. Postnatal desmin-immunopositive pericyte coverage in the mouse cortex (CTX),  
            lateral hypothalamus (LH) and paraventricular nucleus of the hypothalamus (PVN) at  
            P12, P22 and P52 ........................................................................................................... 64 
 
Figure 4.3. Blood vessels in the paraventricular nucleus of the hypothalamus (PVN) were  
           wider than in the mouse cortex (CTX) at P12 and P52 ................................................... 65 
 
Figure 4.4. Prenatal exposure to dexamethasone (dex) impacted blood vessel density in  




Figure 4.5. Prenatal exposure to dexamethasone (dex) impacted blood-brain barrier         
           development in the mouse cortex (CTX) and paraventricular nucleus of the  
           hypothalamus (PVN) at P20 ............................................................................................ 67 
 
Figure 4.6. Prenatal exposure to dexamethasone (dex) impacted desmin-immunoreactive 
            pericyte coverage in the mouse paraventricular nucleus of the hypothalamus (PVN)  
            at P20 ............................................................................................................................. 68 
 
Figure 4.7. Regions selected for analysis ................................................................................... 69 
 
Figure 4.8. Analysis of vascular permeability ............................................................................. 69 
 
Figure 5.1. Prenatal exposure to dexamethasone (dex) does not impact blood vessel density 
            within the mouse paraventricular nucleus of the hypothalamus (PVN) at P50 ............... 88 
 
Figure 5.2. Prenatal exposure to dexamethasone (dex) impacted desmin-immunoreactive   
           pericyte coverage in the male mouse paraventricular nucleus of the hypothalamus  
           (PVN) at P50 .................................................................................................................... 89 
 
Figure 5.3. Prenatal exposure to dexamethasone (dex) impacted total GFAP-immunoreactive  
            astrocytes in the female mouse paraventricular nucleus of the hypothalamus (PVN)   
            at P50 ............................................................................................................................. 90 
 
Figure 5.4. Prenatal exposure to dexamethasone (dex) impacted ir-GFAP surrounding  
           blood vessels in the female mouse paraventricular nucleus of the hypothalamus   
           (PVN) at P50 .................................................................................................................... 91 
 
Figure 5.5. Prenatal exposure to dexamethasone (dex) does not impact the blood-brain     
           barrier development in the mouse paraventricular nucleus at P50 .................................. 92 
 
Figure 5.6. Testing for depression-like behavior using the tail suspension test ......................... 93 
 
Figure 6.1. Blood vessels maintained in vitro ........................................................................... 105 
 
Figure 6.2. Current model of postnatal blood vessel development along with alterations due              
            to excess glucocorticoids during embryonic development in the paraventricular         







CHAPTER 1. INTRODUCTION 
 
Currently, cardiovascular disease (CVD) is the leading cause of death in the United States and 
worldwide (Thayer et al., 2010).  Individuals suffering from CVD are more likely to have the most 
prevalent mental disorder major depressive disorder (MDD; The World Health Report, 2001).  
This co-morbidity constitutes an approximate 20% population prevalence (Reviewed in 
Goldstein et al., 2014) and by 2020 is postulated to be the number one cause of disability 
worldwide (The World Health Report, 2001).  To understand the etiology with hopes of reducing 
the incidence of MDD and CVD, independently and collectively, studies are needed to identify 
potential mechanisms.   
 
A key brain region that may be involved in the comorbidity of CVD and MDD is the 
paraventricular nucleus of the hypothalamus (PVN; Baune et al., 2012; Goldstein et al., 2014).  
The PVN is an important locus for understanding disorders of the hypothalamic-pituitary-adrenal 
(HPA) axis with potential impact for mood disorders and other comorbid disorders with ties to 
PVN functions, including obesity and CVD (Brunton, 2010; Tobet et al., 2013).  HPA axis activity 
is regulated through secretion of corticotropin-releasing hormone (CRH) and arginine 
vasopressin (AVP) from the PVN that act on the pituitary to release adrenocorticotrophic 
hormone (ACTH), which then stimulates the secretion of glucocorticoids from the adrenal cortex 
(Pariante, 2009).  In addition to the HPA axis, neurons in the PVN integrate peripheral signals 
into a succinct neuronal response important for maintaining homeostasis, vasomotor tone, 
energy balance, and behavioral functions (Ferguson et al., 2008; Handa & Weiser, 2013; 
Swanson & Sawchenko, 1983).  In a recent review, glucocorticoids were shown to change the 
neural circuitry within the PVN resulting in HPA dysregulation, similar to the effects observed in 
patients with depression (Levy & Tasker, 2012).  The PVN also contains neurons that attenuate 
hypertension (Braga et al., 2011; Ferguson et al., 2008; Sriramula et al., 2011).  For example, 
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an increase of the Na(+)-K(+)-2Cl(-) cotransporter-1 decreases gamma aminobutyric acid 
(GABA)ergic synaptic inhibition and increases the sympathetic drive from the PVN, which 
contribute to the development of hypertension (NKCC1; Ye et al., 2012).  Therefore, the PVN 
may provide a site for cell-based mechanisms that underlie the co-morbidity of CVD and MDD.   
 
The PVN is comprised of a number of different neuronal phenotypes that are critical for 
regulating many important functions that range from initiating flight or fight responses, 
maintaining homeostasis (Ferguson et al., 2008; Swanson et al., 1983) and regulating the 
physiological response to energetic challenges (Hill, 2012).  The PVN is located in the anterior 
region of the hypothalamus situated along the dorsal portion of the third ventricle (Herman et al., 
2005; Swanson & Sawchenko, 1983).  In the rat it has a volume of approximately 0.5mm3 and 
contains approximately 100,000 neurons (Handa & Weiser, 2013). The PVN has a dense three-
dimensional clustering of cells adjoining the dorsal portion of the third ventricle (Simmons & 
Swanson, 2009).  The neurons of the PVN are characterized by their neuropeptides, including 
CRH, AVP, oxytocin (OT), thyrotropin-releasing hormone (TRH), somatostatin, and angiotensin 
(Armstrong et al., 1980; Biag et al., 2012; Ford-Holevinski et al., 1991; Handa & Weiser, 2013; 
Simmons & Swanson, 2009; Swanson and Sawchenko, 1983).  Neurons within the PVN contain 
receptors for GABA, estrogens, androgens, glucocorticoids, and angiotensin II type 1 and many 
other signaling systems (Bingham et al., 2006; Fan et al., 2012; Lund et al., 2004; McClellan et 
al., 2010; Mitra et al., 2003).  Individually and collectively these cell types and expressed 
receptors distinguish extensive cellular heterogeneity in the PVN. This emphasizes the need to 
understand the relationships among the diverse cellular elements of the PVN in maintaining 
homeostasis and initiating stress responses. 
 
Neurons within the PVN can be grouped by their function (Biag et al., 2012; Handa & Weiser, 
2013).  One such group, referred to as neurosecretory parvocellular neurons, project their axons 
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to the median eminence and release CRH, AVP, TRH and somatostatin into the portal 
vasculature targeting the anterior pituitary.  A second group is comprised of neurosecretory 
magnocellular neurons that have terminals that secrete OT and AVP into general circulation 
through fenestrated capillaries of the posterior pituitary.  A third group of neurons are long-
projecting and directly innervate the brainstem and spinal cord.  The location of these neurons 
in the mouse varies throughout the PVN and parvocellular and magnocellular neurons are 
indistinguishable (Biag et al., 2012).  By contrast in rats, they are grouped into subdivisions 
dependent on cell type and can be distinguished based on size (Handa & Weiser, 2013).  In the 
mouse, the rostral and mid regions house the majority of the neurosecretory parvocellular and 
magnocellular CRH, OT, AVP, TRH and somatostatin neurons and the caudal portion holds the 
majority of long-projection neurons that provide autonomic innervation (Biag et al., 2012).    
 
During fetal development, there are high levels of GABAA and GABAB receptors within the PVN, 
while surrounding the PVN are cells and fibers containing immunoreactive GABA (McClellan et 
al., 2010).  Global deficiencies in GABA signaling through the loss of heterodimeric G protein 
coupled GABAB receptors in mice results in decreased female reproductive function (Catalano 
et al., 2005), altered glucose homeostasis (Bonaventura et al., 2008), generalized epilepsy 
(Prosser et al., 2001), severe memory impairment (Schuler et al., 2001), increased anxiety-like 
behavior (Jacobson et al., 2007; Mombereau et al., 2005), and antidepressant-like behavior 
(Mombereau et al., 2005).  These behavioral changes have been linked to inappropriate 
development of brain cytoarchitecture, including several hypothalamic components (McClellan 
et al., 2006; McClellan et al., 2008).  Region-specific changes in cell position and the level of 
protein expression have been observed in a sex-dependent manner in mice lacking a functional 
GABAB receptor.  For example, within the PVN, mice lacking functional GABAB receptors 
through a gene disruption of the R1 subunit (GABABR1) showed significant alterations in the 
locations of cells containing immunoreactive estrogen receptor alpha selectively in females and 
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a more widely distributed spread of immunoreactive neuronal nitric oxide synthase (nNOS) 
(McClellan et al., 2010).  Changes in levels of immunoreactive proteins within the PVN have 
also been observed in GABABR1 knockout (KO) mice.  There was decreased immunoreactive 
brain-derived neurotrophic factor (BDNF; McClellan et al., 2010) and an increase in 
immunoreactive CRH in the rostral PVN region in females (Stratton et al., 2011). GABA 
signaling within the PVN can also control sympathetic vasomotor tone and contribute to CVD (Li 
& Pan, 2007).  These findings suggest that GABA is important to the development and 
regulation of neurons that come to reside in the PVN. 
 
Among its dense cytoarchitecture, the PVN contains a 3-fold denser blood vessel matrix 
compared to surrounding brain regions across multiple species (Ambach & Palkovits, 1974; 
Finley, 1938; van den Pol, 1997).  There is a lack of studies focused on the development of this 
dense vascular bed.  Increases in PVN vascular density have been shown during postnatal 
development in male rats and differences in density were observed as a function of location 
within the nucleus rather than strictly aligning with magnocellular and parvocellular divisions 
(Menendez & Alvarez-Uria, 1987). While this dense vascular matrix has been known for some 
time (e.g. (Ambach & Palkovits, 1974; Basir 1931; Craigie, 1940; Finley, 1938; Poppi, 1928), its 
development and function have not been well characterized.  Currently whether this unique 
vasculature plays a role in the development of CVD, MDD, or any other disorder remains 
unknown.   
 
If the blood vessels within the PVN experience a postnatal angiogenic period in mice, when this 
occurs should be identified.  Previous studies have shown endocan as a potential marker for 
angiogenesis (Roudnicky et al., 2013; Sarrazin et al., 2010).  Endocan is a secreted 
proteoglycan and has been proposed as a biomarker for cancer.  Recently, antibodies have 
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been developed for endocan, which may identify when the postnatal angiogenic period is 
occurring in the PVN (Frahm et al., 2013).     
 
The blood vessels in the brain vary from those in the periphery.  The brain receives 20% of 
cardiac output yet accounts for only 2% of body mass (Quaegebeur et al., 2011).  These 
complex and highly regulated cerebral blood vessels exist to supply oxygen and nutrients to the 
brain while protecting it from potentially harmful items such as toxins and pathogens (Chip et al., 
2013).  What sets brain blood vessels apart is that a large portion of them maintain a restrictive 
barrier known as the blood-brain barrier (BBB). The purpose of the BBB is to regulate a 
microenvironment necessary for reliable neuronal signaling by protecting the brain from 
potentially harmful items such as toxins. The BBB consists of a continuous layer of endothelial 
cells, which form the walls of blood vessels, connected to one another through tight junctions.  
These tight junction proteins are the initial barrier and restrict permeability by forming a physical 
barrier composed of several different proteins including, but not limited to, the transmembrane 
claudins and occludins that are stabilized by linking to zonula occludens (Reviewed in Abbott et 
al., 2006; Hawkins & Davis, 2005; Iadecola, 2004; Saunders et al., 2013).  Other components of 
the BBB include pericytes and astrocytic endfeet that surround endothelial cells (Hawkins & 
Davis, 2005). Changes in any of these components that together form the BBB could 
compromise its functional integrity.  
 
Pericytes, first described in 1873, are also referred to as Rouget cells (Reviewed in Dore-Duffy 
& Cleary, 2011) and play a role in tight junction formation, structural stability, angiogenesis 
(Armulik et al., 2010; Daneman et al., 2010) as well as regulate vascular stability (Winkler et al., 
2011).  Pericytes have contractile properties that can regulate capillary diameter and blood flow 
through their finger-like processes that ensheath capillary walls (Iadecola, 2004; Winkler et al., 
2011).  Loss of pericytes results in an increased permeability of the BBB (Daneman et al., 
 6 
2010).  Studies imply that during early prenatal development cross-talk between pericytes and 
astrocytes is essential but in vivo work is needed to corroborate this hypothesis (Bonkowski et 
al., 2011). 
 
Astrocytes are glial cells that detect and modulate neuronal activity and blood vessel function 
through regulation of endothelial cells junctions and transport (reviewed in Daneman, 2012).  
Astrocytes have an enrichment of connexin 30 and 43, which form gap junction channels 
allowing ion and small molecule exchange between cells, which develop postnatally in the 
mouse (Ezan et al., 2012).  Inhibition of astrogliogenesis during early postnatal development 
results in increased endothelial cell proliferation, blood vessel diameter and pericyte coverage 
(Ma et al., 2012).  Astrocytic endfeet in close proximity to microvessel walls are specialized and 
contain aquaporin 4 and the Kir4.1 K(+) channel, which are important for maintaining ion and 
volume regulation (Abbott et al., 2006).   
 
Recently, there has been a focus on expanding our understanding of the BBB in the context of 
communication with neurons.  There are coordinated interactions that exists between neurons, 
astrocytes, and pericytes that are essential for the health and function of the central nervous 
system, referred to as the neurovascular unit (NVU; Hawkins & Davis, 2005).  In adulthood, the 
NVU is formed by astrocytic endfeet and pericytes in close proximity to blood vessels (Saunders 
et al., 2013).  Decreases in blood vessel density result in neuronal loss (Bell et al., 2010) and 
within the PVN this loss could potentially result in a wide range of diseases and disorders 
(Quaegebeur et al., 2011). 
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Figure 1.1. Image of blood vessels, pericytes and astrocytic endfeet in the mouse brain.  
High magnification of a blood vessel (green), surrounded by a pericyte (red) and ensheathed 
with astrocytic endfeet (blue). 
 
 
Many assume that the BBB is uniform throughout the brain; however, markers for the BBB in rat 
endothelial cells show differential expression between venules and capillaries as well as 
between capillaries themselves (Saubamea et al., 2012).  Some brain regions, such as the 
circumventricular organs (CVO), do not have a typical BBB.  It is frequently stated that these 
regions lack a BBB (Norsted et al., 2008), but this is likely misleading.  There are differences in 
vascular permeability to dye extravasation among the CVO (Morita & Miyata, 2012).  One 
subset of CVOs had different vascular permeability for both low- and high-molecular-mass 
molecules than the others.  Furthermore, all CVOs have a decrease in permeability compared to 
peripheral organs, indicating some maintenance of barrier function (Morita & Miyata, 2012).  
The CVOs have the ability to modulate their permeability.  A recent study showed that changes 
in feeding state, such as fasting, increased permeability in a CVO known as the median 
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eminence (Langlet et al., 2013).  Therefore, there is much work to be done to look at the BBB in 
a region-dependent manner and how it can vary.   
 
The BBB can be modulated and its breakdown has been implicated in disease onset and 
progression (Dalkara et al., 2011; Gosselet et al., 2011; Hawkins & Davis, 2005; van Sorge & 
Doran, 2011).  During inflammation, tight junctions can open, increase BBB permeability and 
contribute to edema (Abbott et al., 2006) while in patients with disease such as multiple 
sclerosis (Waubant, 2006), HIV, Parkinson’s disease and Alzheimer’s disease there is an 
associated BBB breakdown (Abbott et al., 2006).  During adulthood in mice, loss of pericytes 
diminished cerebral blood flow and increased BBB breakdown resulted in neuronal 
degeneration (Bell et al., 2010).  Spontaneously hypertensive rats exhibit increased BBB 
permeability allowing circulating angiotensin II to leak into the PVN (Biancardi et al., 2013). To 
determine if the physiological relevance of these findings, more context-dependent in vivo 
studies are needed.   
 
One factor that contributes to CVD is prenatal stress (Maccari et al., 2003; Baum et al., 2003).  
In rodent studies, the synthetic glucocorticoid dexamethasone (dex) has been suggested to 
mimic at least one component of maternal stress (O’Regan et al., 2004).  Prenatal exposure to 
dex has been shown to increase anxiety-like (Hossain et al., 2008) and depressive-like 
behaviors in adulthood (Roque et al., 2011).  There are multiple ways that the developing brain 
can be exposed to excess levels of glucocorticoids. First, the glucocorticoid metabolizing 
enzyme 11ß-hydroxysteroid dehydrogenase type 2 (11ß-HSD2) is highly expressed in the 
placenta and fetus, and normally allows approximately 20% of maternal glucocorticoids to reach 
the fetus in an active form (Wyrwoll & Holmes, 2012; Zandi-Nejad et al., 2006). High levels of 
maternal stress, however, may decrease 11ß-HSD2 in the placenta and allow excess active 
glucocorticoids to reach the developing brain. Second, a low protein diet reduces 11ß-HSD2 
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increasing the ratio of active to inactive glucocorticoids reaching the developing fetus (Bertram 
& Hanson, 2002).  Next, glucocorticoids are administered during early gestation (5-6 weeks) to 
mothers whose children are at high risk for congenital adrenal hyperplasia to prevent 
ambiguous genitalia if the fetus is female (Vos & Bruinse, 2010).  Finally, the synthetic 
glucocorticoid dex (Liggins & Howie, 1972) has been administered since 1972 prior to preterm 
delivery to promote lung development and is currently administered in 12% of pregnancies 
(Damsted et al., 2011; Karemaker et al., 2008).  Dex has high glucocorticoid receptor (GR) 
activity, low mineralocorticoid receptor activity, and a 90% bioavailability that peaks in plasma 
within 2 hours (Damsted et al., 2011).  Concerning 11ß-HSD2, dex is a poor substrate and 
therefore not metabolized or affected by it (Holmes et al., 2006; Zandi-Nejad et al., 2006).  
While another synthetic glucocorticoid betamethasone has become the suggested standard 
(Lee et al., 2008), the key is that past, present and future patients have exposure to excess 
glucocorticoids during prenatal development. Therefore, increased glucocorticoids can and do 
reach the fetus, and impact normal development with long-lasting consequences for humans 
although the mechanisms are not well understood. 
 
Prenatal stress has been implicated in causing long-term functional consequences such as 
depression-like behavior (Bale, 2005), hypertension (Levitt et al., 1996) and in humans 
alterations in HPA axis function (Wyrwoll & Holmes, 2012). More specifically, prenatal stress in 
rodents alters GR expression in the hippocampus, elevates levels of basal corticosterone (Levitt 
et al., 1996) and increases CRH mRNA within the PVN (Welberg et al., 2001).  In humans, 
neonatal dex treatment blunts the cardiovascular stress response in children (Karemaker et al., 
2008), but it is unknown if blood vessels in the PVN are also affected.  If so, this could be a 
potential mechanism for dysfunction.  
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Glucocorticoids have been proposed to underlie adult disorders like depression (Wyrwoll & 
Homes, 2012) and at the level of the PVN results in HPA dysregulation (Levy & Tasker, 2012).  
Steroid hormones, like glucocorticoids, transmit extracellular signals into changes in gene 
activity (DeFranco, 1997).  Glucocorticoids and dex bind to GR, and when the complex forms 
can then bind specific DNA sequences and trans-activate particular genes (reviewed in Forster 
et al., 2005).  Glucocorticoids provide negative feedback for HPA axis regulation.  This occurs 
through GR binding to negative glucocorticoid response element (nGRE) sites on the promoter 
of the proopiomelanocortin gene, which represses ACTH (Reviewed in Heitzer et al., 2007).   
 
Concerning the vasculature, excess glucocorticoids modify the molecular composition of the 
BBB in vivo (Malaeb et al., 2007; Sadowska et al., 2009) and in vitro (Forster et al., 2005; Gu et 
al., 2009).  Dex inhibits neovascularization (Nakamura et al., 1992) and alters the BBB by 
increasing tight junction proteins (Forster et al., 2005; Malaeb et al., 2007; Sadowska et al., 
2009).  After dex administration, BBB permeability rapidly decreases (Gu et al., 2009; Hedley-
Whyte & Hsu, 1986). There is an increase in mRNA synthesis for the tight junction protein 
occludin in the presence of glucocorticoids. This is due to the presence of a putative GRE in the 
occludin promoter (Forster et al., 2005).  Another tight junction protein claudin-5 in cell culture 
increases promoter activity and mRNA levels in response to dex (Burek & Forster, 2009).  Dex 
treatment of brain endothelial cells increases expression of the drug efflux transporter P-
glycoprotein in a development-dependent manner (Iqbal et al., 2011).  Prenatal dex also 
changes the vascular area fraction in the hippocampus while increasing it in the amygdala 
(Neigh et al., 2010).  Therefore, glucocorticoids can impact components of the BBB and blood 
vessel density but have not been studied in the context of the PVN.  These findings may provide 
a novel mechanism related to the development of MDD and CVD as observed in humans.   
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To examine the dense PVN vasculature and whether it is susceptible to changes, Chapter 2 
focuses on the postnatal blood vessel development of the PVN in the mouse.  In addition, mice 
lacking functional GABAB receptors were also studied and showed a decrease in vascular 
density providing evidence of vascular regulation for this region.   
 
In trying to identify potential markers of angiogenesis, Chapter 3 examines endocan using 
recently developed monoclonal antibodies.  Instead of being a marker for angiogenesis, 
immunoreactive endocan was present globally throughout the blood vessels in the brain.  This is 
the first study to identify endocan in a non-disease state and suggests endocan is normally 
present within the brain.  Also, prior perfusion with fluorescein isothiocyanate (FITC) prevents 
endocan-immunoreactivity (ir) and provides a novel method for identifying non-functional blood 
vessels.   
 
To determine if excess glucocorticoids during development impacts the vascular network in the 
PVN, pregnant mice were treated with dex (E11-17) and their offspring were examined at P20 
and P50.  For both males and females there was a significant decrease in blood vessel density 
and an increase in extravascular FITC leakage and desmin immunoreactive (ir) pericyte 
coverage indicating a disrupted BBB at P20 within the PVN in Chapter 4.  To establish if these 
were transient or maintained into adulthood, Chapter 5 examined blood vessel density, BBB 
competency, GFAP-ir astrocytes and desmin-ir pericytes within the PVN.  There was a female-
specific decrease in GFAP-ir in dex-treated females and an increase in desmin-ir in dex-treated 
males.  However, there were no differences in density or BBB competency observed at P50.  
Therefore, prenatal exposure to excess glucocorticoids impacted the vasculature within the PVN 
in a sex-specific manner.  In addition, both male and female mice exposed to excess 
glucocorticoids during prenatal development also displayed an increase in depression-like 
behavior demonstrating there are long-lasting behavioral consequences.  
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Overall, the work presented in this dissertation demonstrates that in addition to changes in 




Figure 1.2. Proposed model of postnatal blood vessel development along with alterations 
due to changes during embryonic development.  Neurons within the paraventricular nucleus 
of the hypothalamus (PVN) migrate laterally from the proliferative zone of the third ventricle (3V) 
with age followed by a postnatal angiogenic period that increases the blood vessel density by 
40% (A).  Changes in neuronal migration during development may impact the postnatal 
angiogenic period (B) and subsequently change in the vascular network (green lines) and blood-




CHAPTER 2. THE VASCULATURE WITHIN THE PARAVENTRICULAR NUCLEUS OF THE 
HYPOTHALAMUS VARIES AS A FUNCTION OF DEVELOPMENT, SUB-NUCLEAR 





The paraventricular nucleus of the hypothalamus (PVN) is a cell group that plays important roles 
in regulating sympathetic vasomotor tone, food intake, neuroendocrine and autonomic stress 
responses and cardiovascular function. The developing PVN is surrounded by neuronal 
elements containing, and presumably secreting, gamma-aminobutyric acid (GABA). The 
vasculature of the adult PVN is notably denser than in other brain regions or in the PVN during 
perinatal development. To characterize the postnatal angiogenic process in mice, blood vessels 
were analyzed at P8, 20 and 50 in rostral, mid, and caudal divisions of the PVN in males and 
females. Vascular changes relative to disruption of the R1 subunit of the GABAB receptor were 
evaluated at P8 and P20. For defined regions of interest within the PVN there were age 
dependent increases in blood vessel lengths and branching from P8 to 20 to 50 with the most 
notable increases in the middle region. Loss of GABAB receptors did not influence vascular 
characteristics at P8 in any region, but by P20 there was significantly (20%) less blood vessel 
length and branching in the mid-PVN region versus wild type. These findings suggest that the 
loss of GABAB signaling may lead to a late developing defect in angiogenesis.  The loss of 
vascularity with defective GABAB signaling suggests that neurovascular relationships in the PVN 
may be an important locus for understanding disorders of the hypothalamic-pituitary-adrenal 
axis with potential impact for psychiatric mood disorders along with other comorbid disorders 





The paraventricular nucleus of the hypothalamus (PVN) is critically involved in regulating a 
number of homeostatic and behavioral functions.  These include stress responses, energy 
balance, as well as autonomic nervous system regulation and neuroendocrine functions 
(Swanson & Sawchenko, 1983; Ferguson et al., 2008).  Neurons located within the PVN have 
been characterized as containing a number of neuropeptides including corticotropin-releasing 
hormone (CRH), oxytocin (OT), thyrotropin-releasing hormone (TRH), and arginine vasopressin 
(AVP; Armstrong et al., 1980; Ford-Holevinski et al., 1991; Swanson & Sawchenko, 1983; 
Simmons & Swanson, 2009).  Receptors for gamma aminobutyric acid (GABA), estrogens, 
androgens and glucocorticoids are also expressed throughout the brain and heavily within the 
PVN (Mitra et al., 2003; Lund et al., 2004, Bingham et al., 2006; McClellan et al., 2010).  
Individually and collectively these cell types and expressed receptors distinguish extensive 
cellular heterogeneity in the PVN.     
 
Brain nuclei are characterized by the clustering of neurons into groups, which is the 
predominant organization for the hypothalamus. The PVN has a unique three-dimensional 
clustering of cells adjoining the dorsal portion of the third ventricle (Simmons & Swanson, 2009). 
Interestingly, the PVN can also be characterized by its dense vascularization (Ambach & 
Palkovitz, 1974; van den Pol, 1997).  While this dense vascular matrix has been known for 
some time (e.g. Finley, 1938), its development and function has not been well characterized.  
One report using male rats indicated that the extensive vascularization occurs during postnatal 
development and may differ by region within the PVN (Menendez & Alvarez-Uria, 1987).  The 
development of PVN vascular density has not been investigated in other species to our 
knowledge.  The importance of examining multiple species is underscored by the several well-
characterized differences in neuronal organization for the PVN between rats and mice (Kádár et 
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al., 2010; Biag et al., 2012). Given the potential that vascular developmental processes are 
susceptible to alterations, the current study examined the vascular development in the mouse 
PVN in the context of a disruption of GABA signaling as described below.  
 
In adulthood, GABA is the major inhibitory neurotransmitter throughout the brain, however, 
during development GABA is usually excitatory and often morphogenetic (McClellan et al., 
2006, 2008, 2010; Davis et al., 2002).  Heterodimeric G protein coupled GABAB receptors have 
been shown to be important for appropriate development of brain cytoarchitecture, including 
several hypothalamic components (McClellan et al., 2006, 2008).  Recent studies have shown 
that loss of GABA signaling within the PVN through the GABAB R1 leads to a decrease in levels 
of immunoreactive brain-derived neurotrophic factor (BDNF; McClellan et al., 2010) and region-
specific differences in immunoreactive CRH levels (Stratton et al., 2011).  In addition, mice 
lacking a functional GABAB receptor show significant alterations in the locations of cells 
containing immunoreactive estrogen receptor alpha and neuronal nitric oxide synthase (nNOS; 
McClellan et al., 2010).  Other developmental events are more dependent on GABAA signaling 
(chloride channel) rather than GABAB signaling, such as the migration of neurons containing 
gonadotropin releasing hormone (GnRH) from the nasal compartment into the brain (Tobet et 
al., 2001).   
 
The current study examined the postnatal development of the vasculature within the PVN in 
mice.  Rostral-to-caudal analysis showed differences in vascular density within the PVN that 
increased strongly in the second postnatal week.  Finally, mice lacking a functional GABAB 
receptor showed a decreased blood vessel density most strongly within the mid region of the 
PVN.    
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Materials and Methods 
 
Animals 
All mice were bred on a C57BL/6J background.  GABAB R1 subunit disrupted mice were 
generated through the insertion of a gene encoding β-galactosidase into the coding region of the 
R1 subunit (Prosser et al., 2001; McClellan et al., 2008).  Mice were maintained in plastic cages 
with aspen bedding (autoclaved Sani-chips, Harlan Teklad, Madison, WI, USA) in the Painter 
Building of Laboratory Animal Resources at Colorado State University.  Food (#8640, Harlan 
Teklad, Madison, WI, USA), tap water and environmental enrichment were provided ad libitum 
in a 14/10h light/dark cycle.  Procedures for animal care and handling were approved by, and 
conducted in accordance with, the Colorado State University Institutional Animal Care and Use 
Committee guidelines. 
 
The day of birth was designated postnatal day (P)0.  Mice were deeply anesthetized by inhaling 
isofluorane (Vet One).  Brains for analysis were removed and immersion fixed with 10 ml (P8) or 
20 ml (P20) 4% paraformaldehyde in 0.1M phosphate buffer (pH 7.4) overnight.  Brains were 
changed into 0.1M phosphate buffer for storage at 4°C prior to sectioning and processing for 
immunohistochemistry.  Body weights were measured and sex determination was confirmed by 
PCR analysis for the SRY gene on the Y chromosome.  Mice were genotyped for the GABAB R1 
knockout allele using a standard Taq polymerase PCR kit (Qiagen, Valencia, CA).  
Animals per group are as follows:  n=3 (P8 female KO, P8 male KO, P20 male KO) and n=4 
(P8 female WT, P8 male WT, P20 female WT, P20 male: WT, P20 female KO). 
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Immunohistochemistry 
Brains were embedded in 5% agarose and 50µm coronal sections were cut using a vibrating 
microtome (Leica VT1000S) at 4°C.  Free-floating serial sections were processed as previously 
reported (Davis et al., 2002; Tobet et al., 1996) with slight modifications.  Briefly, sections were 
collected in 0.05M phosphate-buffered saline (PBS), pH 7.5 and excess unreacted aldehydes 
were neutralized in 0.1M glycine for 30 minutes followed by 0.5% sodium borohydride for 15 
minutes.  Sections were washed in PBS then incubated in a PBS blocking solution (5% normal 
goat serum (NGS), 0.5% Triton X-100 (Tx), and 1% hydrogen peroxide) for at least 30 minutes.  
Sections were then incubated in primary antiserum directed against platelet endothelial cell 
adhesion molecule (PECAM also known as CD31, 1:30; BD Biosciences, San Jose, CA) in 1% 
BSA and 0.5% Tx.  Sections were incubated for 2 nights at 4°C in primary antisera.  Sections 
were then washed at room temperature with 1% NGS and 0.02% Tx in PBS.  Sections were 
incubated for 2 hrs in a secondary biotin conjugated donkey anti-rat antiserum (1:1000; Jackson 
Immunoresearch, West Grove, PA) in PBS containing 1% NGS and 0.32% Tx.  As a tertiary 
reaction, sections were incubated in a Vectastain reagent (3µl/ml solutions A and B - Vectastain 
ABC Elite kit; Vector Laboratories, Burlingame, CA) at room temperature for 1 hr. After 1 hr of 
washing in Tris-buffered saline (pH 7.5), reaction product was developed over 5min in Tris-




Sections were viewed and images digitized using an Olympus BH2 microscope with an Insight 
QE digital camera in Spot Advanced Software.  Using a 40x objective, 300µm x 224 µm serial 
bilateral images were collected throughout the entire PVN.  Images were processed to improve 
contrast using Adobe Photoshop (version CS for Macintosh). Total blood vessel length and the 
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number of branches were used to characterize the vasculature in each region of interest either 
within the PVN or in a lateral cortical control region.  Branch points were manually counted and 
a bilateral average was calculated for each distinct PVN region (rostral, mid, and caudal).  There 
was an average of 2 sections per region with a range of 1 to 3.  There was no consistency in an 
increase or decrease in number of sections for a specific age, sex or genotype.  For blood 
vessel length, images were light corrected (Image J, version 1.43u), analyzed for length using 
Angiogenesis Tube Formation (Metamorph, version 7.7.0.0, Molecular Devices, Inc.)  For each 
animal both sides of the PVN and parietal cortex were quantified in each section. For each 
region a bilateral average was generated (rostral, mid, caudal) and the average value was taken 
for analysis.  Statistical significance was determined by ANOVA as sex X genotype (wild type 
vs. knock out) X age (P8 vs. P20) X region as a repeated measure using SPSS software (SPSS 
Inc., Chicago, IL.).  Values are reported as mean + SEM and p < 0.05 was considered 





A few days after birth (P4) the vascular pattern of the PVN was similar in density to the 
surrounding hypothalamus and then proceeded to expand over the next 3 weeks as shown in 
females (Fig. 2.1A-E).  Even approximately one week after birth (P8) the vasculature of the PVN 
was difficult to distinguish from the surrounding hypothalamus (Fig. 2.1B).  However, by P12 
there was a discernible increase in the vasculature within the PVN compared to surrounding 
brain regions (Fig. 2.1C).  This increase in blood vessel density was expanded by weaning at 
P20 (Fig. 2.1D) and maintained past puberty into young adulthood on P50 (Fig. 2.1E).   
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Since there was a visible increase in blood vessel density within the PVN throughout 
development, we quantified two aspects of this density, vascular length and branching, 
throughout the rostral (Fig. 2.1F), mid (Fig. 2.1G), and caudal (Fig. 1H) aspects of the nucleus.  
The vascular pattern shown in a representative female clearly differed from rostral-to-caudal 
and the densest region was in the middle of the Nissl-defined nucleus at P12 (Fig 1G).  There 
was a notable disparity in the most caudal region where the vasculature within the nuclear 
pattern discernible by Nissl-stain was not notably denser than in the surrounding hypothalamus 
(Fig. 1H).    
 
Through development, there was an increase in blood vessel lengths within the PVN. Within the 
rostral, mid and caudal regions, collectively, there were notable increases in blood vessel length 
on P20 compared to P8 for both males and females (Fig. 2.2; F(1,19) = 136.7 p < 0.001).  On 
P20, there was a significant 30% greater blood vessel length in the mid region as compared to 
the rostral and caudal (F(2,13) = 23.7, p < 0.001).  In mice lacking a functional GABAB receptor, 
there was a significantly greater blood vessel length within the total PVN on P20 as compared to 
P8 (P < 0.05).  However, the mid region of the KO did not have the same increased level of 
blood vessel lengths in the mid region on P20 as observed in WT (Fig. 2.2).  There was 20% 
less blood vessel length within the mid region in GABABR1 KO mice as compared to WT 
(F(2,13)=4.95, p < 0.05).  This contrasts with a non-significant 13% decrease rostrally and a 
slight 4% increase caudally. This suggests that ineffective GABAB signaling may have had an 
impact on the postnatal vascular pattern within the PVN.     
 
There was an apparent decrease in blood vessel density at P20 in mice lacking a functional 
GABAB receptor (Fig. 2.3B) compared to wild type (Fig. 2.3A).  Blood vessel branch points were 
counted as another measure of vascular patterning at P20 between male and female wild type 
versus mice lacking a functional GABAB receptor (Fig. 2.3C).  There were a greater number of 
 20 
blood vessel branch points in the mid region compared to the rostral or caudal regions (F(2,10) 
= 4.8, p < 0.05).  Mice lacking a functional GABAB receptor had significantly less blood vessel 
branching within the mid region as compared to WT (F(1,10) = 3.4, p < 0.05).  Results for 
branch points complemented the data for total blood vessel lengths.  There were no significant 
differences in either parameter by sex. 
 
To determine if blood vessel density was only altered locally or was impacted more globally, an 
identically sized region of interest was defined and analyzed in the parietal cortex (CTX) in the 
same sections (Fig. 2.4A-D).  For CTX, there was a small (~10%), but significant, overall 
decrease in blood vessel length in both male and female mice lacking functional GABAB 
receptors (Fig. 2.4D) compared to male and female wild type (Fig. 2.4B; F(1,10) = 27.9, p < 
0.01).  
 
In addition to impacting the blood vessel density within the PVN, both male and female 
GABABR1 KO mice were 25% lighter when weighed prior to sacrifice on P20 with no evidence 
of a sex difference (WT = 8.1+ 0.37 (n=8), KO = 6.03 + 0.47 (n=7), p < 0.05) as previously 
observed (Prosser et al., 2001).  There was no difference in body weight at P8 for sex or 





The PVN contains a number of different neuronal phenotypes that are critical for regulating 
many important functions that range from initiating flight or fight responses to maintaining 
homeostasis (Swanson & Sawchenko, 1983; Ferguson et al., 2008).  The current study 
characterizes the development of the vasculature within the PVN in C57BL/6 mice. There is a 
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postnatal angiogenic period within the PVN that results in increased blood vessel density that is 
maintained into adulthood. Importantly, this increase is likely regulated by neural factors such as 
GABA.  PVN vasculature was much less developed in mice in which GABAB signaling was 
deficient. Such regulated changes in vascular patterning may lead to altered function in 
adulthood that can be traced back to PVN function.   
 
PVN vasculature comparison: Rats versus Mice 
A number of studies have characterized the dramatic blood vessel density within the adult PVN 
(e.g. van den Pol, 1997).  In rats, there are 3-fold more blood vessels in the PVN (van den Pol, 
1997) than in other brain regions.  Increases in PVN vascular density have been noted during 
postnatal development in rats and differences in density were observed as a function of location 
within the nucleus rather than strictly aligning with magnocellular and parvocellular divisions 
(Menendez & Alvarez-Uria, 1987). This is consistent with results of the current study in mice 
where there was a postnatal increase in blood vessels, specifically the mid region, of the PVN.  
Though mice do not have distinct magnocellular/parvocellular divisions as in rats, the mid region 
does contain more neurons compared to rostral or caudal (Biag et al., 2012).      
 
As a number of characteristics differ between rats and mice (Bonthuis et al., 2010), so too are 
their differences in PVN vascular development. Rats were reported to have a dramatic increase 
in blood vessel density (5 times) in the PVN on the day of birth that decreased quickly by P2 
(1.5 times).  This was followed by a more persistent increase that resulted in a final 3-fold 
difference compared to other brain regions (Menendez & Alvarez-Uria, 1987).  Based on the 
results of the current study, mice do not have an initial increase followed by a decrease in blood 
vessel density around postnatal day 2 (Menendez & Alvarez-Uria, 1987) suggesting the factors 
responsible for the postnatal angiogenic period in mice that starts around P8 may be delayed 
compared to the expression in rats.     
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Potential Consequences 
The physiological roles of this postnatal increase in blood vessel density within the PVN remain 
unknown.  It has been suggested that the greater vascularization of the PVN does not lead to a 
high basal metabolic capacity of the neurons (Badaut et al., 2000).  The level of blood flow 
through the PVN is similar to surrounding brain regions even though related to other regions it 
has a high vascular network that is hypothesized to serve as a large reserve capacity for blood 
flow (Badaut et al., 2000).  However, significantly fewer blood vessels within the PVN as seen in 
GABABR1 KO mice may reduce accessibility to oxygen and nutrients and impact a neurons 
ability to effectively relay its metabolic needs (Gyurko et al., 2002).  It has been hypothesized 
that the vast blood vessel network of the PVN may be used to detect plasma osmotic pressure 
by magnocellular neurons (Badaut et al., 2000) that are abundant in the mid region in mice 
(Biag et al., 2012).  A decrease in vasculature may result in PVN neurons not being able to 
provide proper feedback resulting in dysfunction.  It is unclear whether other mechanisms 
altered in the GABABR1 KO mice may be responsible for this decrease in blood vessel 
development.  However, examining the development of the PVN from neuronal to vascular may 
provide insight to function as well as help delineate dysfunction.   
 
In the current study the loss of GABAB function through deletion of the R1 subunit resulted in 
decreased vascular density within a restricted portion of the PVN and a region of the parietal 
cortex.  For the PVN, it is notable that this decrease in blood vessel density was spatially 
restricted to the mid region, which has the densest neuronal packing viewable by Nissl-stain 
(Biag et al., 2012).  Changes in cell position and the level of protein expression in a region-
specific manner have been observed in mice lacking a functional GABAB receptor (McClellan et 
al., 2010; Stratton et al., 2011).  GABA modulates immunoreactive CRH specifically in the 
rostral PVN based on GABABR1 KO female mice having increased levels of immunoreactive 
CRH compared to controls (Stratton et al., 2011).  For the central, or mid PVN, GABABR1 KO 
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mice had immunoreactive nNOS that was more widely distributed spatially than in controls 
(McClellan et al., 2010).  Interestingly, there has been no indication of an influence of genetic 
disruption of nNOS itself on neuronal or vascular characteristics in the PVN (unpublished 
observations) in mice for which the loss of NOS activity is complete (Gyurko et al., 2002). Since 
the mid region of the mouse houses the majority of CRH, OT, AVP, TRH and somatostatin 
neurons as compared to the rostral or caudal regions (Biag et al., 2012), changes in vascular 
characteristics may alter their ability to respond properly to signals from the periphery.   
 
Decreases in blood vessel density in the cortex of GABABR1 KO mice show the potential global 
importance of the neurovascular relationship.  These mice are lighter than wild type and have 
changes in reproduction (Catalano et al., 2005), altered glucose homeostasis (Bonaventura et 
al., 2008), develop generalized epilepsy (Prosser et al., 2001), demonstrate an increase in 
anxiety-like behavior (Jacobson et al., 2007; Mombereau et al., 2005), and show 
antidepressant-like behavior (Mombereau et al., 2005).  Whether these are direct or indirectly 
tied to changes in brain vascular function remains to be determined.     
 
GABA impacts the second angiogenic period 
The initial vascular development of the PVN was not disturbed due to altered GABAB signaling.  
On P8, there were no significant differences for blood vessel lengths or the number of branch 
points between the Nissl-defined PVN in the rostral, mid or caudal region of the PVN compared 
to the surrounding hypothalamus.  This might suggest that the most important period for GABAB 
signaling is during the postnatal period when vessel expansion normally begins.  However, it is 
too early to rule out fetal antecedent events that could still play important roles. Cells containing 
estrogen receptor alpha, nNOS and BDNF are already disrupted to differing extents at birth 
(McClellan et al., 2010) and malfunctions in these cells (or others) may interact with specific 
angiogenic factors selectively at the later time points. Studies are needed to examine changes 
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in factors known to influence vascular development and plasticity, such as vascular endothelial 
growth factor, to shed light on why GABABR1 KO mice do not undergo a robust angiogenic 
period as compared to wild type.    
 
In summary, the results of the current study show a progressive postnatal angiogenic period 
with the greatest increase in blood vessel density occurring in the mid region in the mouse PVN. 
In addition, the data suggest that the loss of GABAB signaling may lead to a late developing 
defect in PVN angiogenesis. The relative decrease of vascularity with defective GABAB 
signaling suggests that neurovascular relationships in the PVN may be an important locus for 
understanding disorders of the hypothalamic-pituitary-adrenal axis with potential impact for 
mood disorders and other comorbid disorders with ties to PVN functions, including obesity and 













Figure 2.1. Blood vessels within the paraventricular nucleus of the hypothalamus (PVN) 
across development and region. Digital images in females (A-E) show that during early 
postnatal development, on P4 (A) and P8 (B), the blood vessel pattern was indistinguishable 
from the surrounding regions.  By P12 (C) there was a dramatic increase in blood vessel density 
within the PVN compared to the surrounding regions.  On P20 (D) and into young adulthood on 
P50 (E), the increase in vasculature was maintained. Representative digital images (F-G) of 
50µm sections from a P12 female illustrate that the rostral (F) and mid (G) PVN were dense in 
neuronal elements (Nissl-stain) and blood vessels (PECAM immunoreactive) compared to 
surrounding brain regions.  For the caudal region (H) of the PVN, the density of neuronal 
elements easily illuminates the nucleus, but the vascular density was more similar to the 
surrounding hypothalamus.  The scale bar (100µm) shown in lower left corner panel A applies to 






Figure 2.2. Changes in total length of blood vessels as a function of age, sex, 
paraventricular nucleus of the hypothalamus (PVN) region and GABAB receptor function.  
The graph illustrates changes in total length of blood vessels as a function of age, sex, PVN 
region, and GABAB receptor status.  For WT, there were significantly greater blood vessel 
lengths in rostral, mid, and caudal regions at P20 as compared to P8 (p < 0.05).  On P20, there 
was also a significantly greater blood vessel length in the mid region of the PVN as compared to 
the rostral or caudal regions (p < 0.05).  Mice lacking a functional GABAB receptor had 
significantly less blood vessel length in the mid region compared to wild type (p < 0.05).  There 







Figure 2.3. Changes in blood vessels density in the paraventricular nucleus of the 
hypothalamus (PVN) as a function of GABAB receptors. Images (A-B) show a representative 
mid PVN region in wild type (A) and in mice lacking a functional GABAB receptor (B) on P20.  
Matched sections using immunoreactive platelet endothelial cell adhesion molecule (PECAM) to 
visualize blood vessels show a decrease in blood vessel density for mice lacking functional 
GABAB receptors compared to wild type.  The graph (C) shows on P20 there was significantly 
greater blood vessel branching in the mid region as compared to rostral or caudal for both 
males and females (p < 0.05).  Mice lacking a functional GABAB receptor had significantly less 
blood vessel branching in the mid region compared to wild type (p < 0.05). The scale bar 




Figure 2.4. Changes in blood vessel length in the mid region of the paraventricular 
nucleus of the hypothalamus (PVN) and the cortex (CTX) at the lateral edge of the section 
as a function of GABAB receptors. Images (A-D) on P20 show a decrease in blood vessel 
density for mice lacking functional GABAB receptors (C-D) compared to wild type (A-B) in mid 
sections of the PVN (A, C), and CTX (B, D). The graph (E) shows on P20, there were 
significantly less blood vessel lengths in mice lacking a functional GABAB receptor in the PVN 
and CTX compared to wild type (p < 0.05). In the mid region, the PVN contains more blood 
vessels than the CTX.  The decrease in blood vessel length in GABAB  R1 subunit KO mice was 
twice as great in the PVN compared to the CTX. The scale bar (100µm) shown in lower left 
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CHAPTER 3. ENDOCAN IMMUNOREACTIVITY IN THE MOUSE BRAIN: METHOD FOR 





Endocan is a secreted proteoglycan that has been shown to indicate angiogenic activity: 
remodeling in several tumor types in humans and mice. Serum endocan levels also indicate 
prognosis and has been proposed as a biomarker for certain cancers. Recently, monoclonal 
antibodies directed against mouse endocan have been developed allowing for further 
characterization of endocan function and potentially as a marker for angiogenesis through 
immunoreactivity in endothelial tip cells. The results of the current study show that endocan 
immunoreactivity in the mouse brain is present in blood vascular networks including but not 
limited to the cortex, hippocampus and paraventricular nucleus of the hypothalamus in 
C57BL/6J and FVB/N mice. Endocan immunoreactivity did not vary during postnatal 
development or by sex. Interestingly, after vascular perfusion with fluorescein isothiocyanate 
(FITC), endothelial cells positive for FITC were immunonegative for endocan suggesting FITC 
interference with the immunohistochemistry. A small number of FITC-negative blood vessels 
were endocan immunoreactive suggesting the identification of new blood vessels that are not 
yet functional. The current study shows that endocan is normally present in the mouse brain and 









Endocan, previously known as endothelial cell-specific molecule-1 (ESM-1), was identified with 
its localization restricted to endothelial cells (Lassalle et al., 1996). Endocan is a secreted 
dermatan sulfate proteoglycan that has been suggested to promote angiogenesis (Chen et al., 
2012). Elevated levels of endocan mRNA negatively correlate with cancer survival rates and 
overexpression of endocan leads to tumor formation (Scherpereel et al., 2003; Depontieu et al, 
2012).  High endocan mRNA levels in human tumor tissue correlates with prognosis and is 
proposed to serve as a biomarker for inflammatory disorders and cancer development and 
continues to be investigated as a target for cancer therapy (Sarrazin et al., 2006).  Increased 
levels of endocan have been detected in the serum of sepsis patients (Sarrazin et al., 2006; 
Sarrazin et al., 2010; Scherpereel et al., 2003).  Overall, endocan has shown promise as an 
indicator of angiogenesis and disease progression.    
 
Endocan has also been studied in activated endothelial cells referred to as tip cells, which 
indicate newly forming blood vessels (Sarrazin et al., 2010, Del Toro et al. 2010). Endocan 
mRNA is upregulated on tumor-associated blood vessels and it is proposed that modification of 
endocan interactions with vascular endothelial growth factor receptors may inhibit tumor 
angiogenesis (Roudnicky et al., 2013).  However, beyond its detection in endothelial cells 
undergoing angiogenesis, the role of endocan is not well understood. 
 
To visualize and characterize endocan distributions, monoclonal antibodies were generated to 
study roles in angiogenesis, cancer, and other diseases. Antibody clones MEP14 and MEP19 
were generated against the C-terminus of human endocan and recognize both rat and mouse 
endocan. (Depontieu et al, 2012). The generation of these antibodies may provide a useful tool  
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to characterize changes in the distribution or levels of immunoreactive endocan under normal or 
disease states, and potentially its function.   
 
The goal of the current study was to use selective antibodies directed against endocan to study 
the developing blood vessel network within the paraventricular nucleus of the hypothalamus 
(PVN).  The PVN develops an unusually dense vasculature following a postnatal angiogenic 
period that occurs between postnatal (P) days 8-12 in the mouse (Frahm et al., 2012).  The 
current study examined endocan as a potential marker for angiogenesis, which within the PVN 
may be coordinated with the postnatal angiogenic period. 
 
In examining blood vessels and blood-brain barrier competency, several studies have utilized 
the small molecule dye fluorescein isothiocyanate (FITC).  When perfused through the 
vasculature, FITC accumulates in endothelial cell nuclei and binds covalently to cellular 
components (Miyata & Morita, 2011).  This allows for visualization of functional blood vessels 
and the ability to double or triple label for other proteins of interest in relevant vasculature.  
Extravascular FITC leakages can also indicate a compromised blood-brain barrier (Miyata & 
Morita, 2011).  Mouse brains were processed for endocan with or without prior vasculature 
perfusion of FITC.  
 
Overall, the current experiments demonstrated that immunoreactive endocan is present in a 
pattern that mirrors the vasculature throughout the brain only in certain mouse strains.  Prior 
vascular perfusion with FITC prevented detection of immunoreactive endocan.  Therefore, the 
use of FITC may provide a novel method to identify non-functional blood vessels using 




Materials and Methods 
 
Animals 
Male and female mice were on a mixed C57BL/6JxS129xCBA background (Solomon et al., 
2012), or pure bred C57BL/6J or FVB/N backgrounds. The day of birth was designated P0.  For 
tissue collection, mice were anesthetized by ketamine (80 mg/kg) and xylazine (8 mg/kg) and 
transcardially perfused with heparanized PBS with or without FITC (ThermoFisher Scientific, 
MW 389.38) followed by 4% paraformaldehyde in 0.1M phosphate buffer (pH 7.4; modified from 
Miyata & Morita, 2011). Brains were removed, post fixed overnight, then changed into 0.1M 
phosphate buffer for storage at 4°C.  
 
Mice were maintained in plastic cages with aspen bedding (autoclaved Sani-chips, Harlan 
Teklad, Madison, WI, USA) in the Painter Building of Laboratory Animal Resources at Colorado 
State University. Food (#8640, Harlan Teklad, Madison, WI, USA) with filtered tap water and 
environmental enrichment was provided ad libitum in a 14/10h light/dark cycle.  Animal care and 




Tissue was processed as previously described (Frahm et. al., 2012) in an antigen retrieval 
immunohistochemical protocol.  Briefly, brains were embedded in 5% agarose and cut coronally 
into 50µm sections using a vibrating microtome (Leica VT1000S).  Free-floating serial sections 
were collected in 0.05M phosphate-buffered saline (PBS), pH 7.5.  Excess unreacted aldehydes 
were neutralized in 0.1M glycine followed by 0.5% sodium borohydride.  Sections were washed 
in room temperature PBS then were washed in sodium citrate (0.05 M, pH 8.6). The sections 
were then placed into sodium citrate buffer preheated to 80°C to promote antigen retrieval 
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(Dellovade et al., 2001). They were allowed to slowly come back to room temperature after 
which they were returned to PBS for additional washes.  Sections were washed in PBS then 
incubated in a PBS blocking solution (5% normal goat serum (NGS), 0.5% Triton X-100 (Tx), 
and 1% hydrogen peroxide).  Sections were then incubated in primary monoclonal antibodies 
directed against endocan (either clone MEP14 or MEP19, Lunginnov, Lille, France) or platelet 
endothelial cell adhesion molecule (PECAM also known as CD31, 1:30; BD Biosciences, San 
Jose, CA, USA).  All sections were incubated at 4°C overnight in primary antibodies.  Sections 
were then washed in room temperature with 1% NGS and 0.02% Tx in PBS.  Sections were 
incubated with the appropriate secondary antibodies for either biotin conjugated donkey anti-
mouse antibodies (1:2500; Jackson Immunoresearch, West Grove, PA), biotin conjugated 
donkey anti-mouse (1:1000; Jackson Immunoresearch) or Cy3 conjugated anti-mouse (1:200, 
Jackson Immunoresearch) in PBS containing 1% NGS and 0.32% Tx.  For brightfield, sections 
were incubated in a Vectastain reagent (3µl/ml solutions A and B - Vectastain ABC Elite kit; 
Vector Laboratories, Burlingame, CA) at room temperature.  After washing in Tris-buffered 
saline (pH 7.5), reaction product was developed in Tris-buffered saline containing 0.025% 
diaminobenzidine, 0.02% nickel, and 0.02% hydrogen peroxide. 
 
Data Collection 
Brightfield images were acquired using an Olympus BH2 microscope with an Insight QE digital 
camera in Spot Advanced Software. Fluorescent images were acquired on a Zeiss 510-Meta 
laser-scanning confocal microscope.  FITC fluorescence was imaged using a 488/543 nm 
bandpass filter and emission detected using a 505/530 nm bandpass emission filter.  Cy3 
fluorescence indicating endocan was imaged using a 488/543 nm bandpass filter and emission 
detected using a 585/615 nm bandpass emission filter.  Z-stacks were taken with 6 layers every 





Endocan immunoreactivity at postnatal day 12 
Brains at P12 were examined for immunoreactive endocan during the postnatal angiogenic 
period specific to the PVN (Frahm et al., 2012).  The distribution of immunoreactive endocan 
resembled the normal blood vessel pattern in the PVN, cortex (CTX) and Hippocampus (figure 
3.1).  Previous studies examining tumors showed that endocan mRNA correlated with newly 
forming blood vessels (Sarrazin et al., 2010, Del Toro et al. 2010).  However, the current 
findings suggest immunoreactive endocan is detectable within virtually all of the vasculature of 
the brain at P12 in FVB/N mice.   
 
Endocan immunoreactivity at postnatal day 20 
To determine if the distribution of immunoreactive endocan varied by age, brains from FVB/N 
(figures 3.2a-c in brightfield) and C57BL/6J  (figures 3.2d-g by immunofluorescence) mice were 
examined at P20.  These strains were selected because they are commonly utilized in our 
laboratory and others.  The distribution pattern of immunoreactive endocan again was 
consistent with general blood vessel patterns.  There was immunoreactive signal throughout the 
brain, although images are specifically provided for cortex (figure 3.2a,d), hippocampus (figure 
3.2b,e) and PVN (figure 3.2c, f) in C57BL/6J and FVB/N background mice. There was no 
labeling in the absence of primary antibody in control sections (figure 3.2g).   
 
Endocan immunoreactivity in FVB/N and C57BL/6J xS129xCBA mixed background mice at 
postnatal day 20 
We next determined endocan immunoreactivity at P20 in a C57BL/6J xS129xCBA mixed 
background mouse used in unrelated experiments due to a specific gene disruption (Solomon et 
al., 2012). C57BL/6JxS129xCBA mice not containing the altered allele were examined 
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alongside FVB/N mice.  The distribution of immunoreactive endocan was similar in the cortex, 
hippocampus and PVN in FVB/N mice (figure 3.3a-c) compared to C57BL/6J mice (figure 3.1a-
c).  Matched sections demonstrate there was no endocan immunoreactivity in the cortex, 
hippocampus or PVN (3.3d-f) of C57BL/6J xS129xCBA mice using MEP19.   
 
Prior vascular perfusion of FITC blocked Endocan immunoreactivity 
The perfusion of FITC allows for visualization of blood vessels and the localization of its 
extravascular leakage that likely indicates compromise of blood-brain barrier function (Miyata & 
Morita, 2011).  However, in C57BL/6J and FVB/N mice, vascular perfusion of FITC prior to 
application of antibodies directed against endocan blocked endocan immunoreactivity (figure 
3.4a, 3.4g).  Images in figure 4a and 4d show blood vessels labeled with FITC indicating 
functional blood vessels.  Only restricted blood vessels or blood vessels devoid of FITC 
contained endocan immunoreactivity (figure 3.4b, e). Confocal microscopy showed no overlap 
or colocalization between FITC and endocan (figure 3.4c, f).  Brightfield images also showed 
immunoreactive endocan in a much more restricted number of blood vessels (figure 3.4g, h).  
Labeling with antibodies against platelet endothelial cell adhesion molecule (PECAM), a protein 
also present in endothelial cells, was not impacted due to prior FITC perfusion (figure 3.4i).  
These studies suggest that vascular perfusion of FITC prior to endocan processing might 





Elevated endocan has been observed in tumor endothelial cells in human glioblastomas arising 
from cell types such as astrocytes and oligodendrocytes (Maurage et al., 2009) and pituitary 
adenomas (Cornelius et al., 2012).  Endocan immunoreactivity has also been found in normal 
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human pituitary tissue specifically in endocrine cells, demonstrating that endocan is not limited 
to endothelial cells (Cornelius et al., 2012).  Previous studies have also identified endocan as a 
potential marker for angiogenesis (Sarrazin et al., 2010, Roudnicky et al., 2013).  However, the 
recent production of antibodies directed against endocan allows a greater sensitivity for 
visualizing its presence and distribution, particularly in the mouse brain.  Instead of being in a tip 
cell distribution, immunoreactive endocan was visualized in a global blood vessel pattern at P12 
and P20 in brains from C57BL/6J and FVB/N mice. This identification of endocan 
immunoreactivity in mouse brain endothelium calls for further examination of its potential 
function in mouse vasculature.  The presence of immunoreactive endocan in the endothelial 
cells of the brain vasculature may provide insight into the potential source of endocan detected 
in the serum of healthy humans and mice (Depontieu et al, 2012).  
 
Prior studies using northern blot and in situ hybridization analyses of mouse brain (Abid et al., 
2006) or human tissue (Lassalle et al., 1996) were unable to detect endocan. There are at least 
2 potential reasons for lack of mRNA when immunoreactive protein is found. First, the sensitivity 
of the mRNA methods may have been lower than the sensitivity of the immunohistochemistry 
with the new monoclonal antibodies used in the current study. Secondly, it is possible that since 
endocan is a secreted proteoglycan, that immunoreactive endocan in brain is accumulated from 
the circulation after synthesis in peripheral sites. However, the detection of immunoreactive 
endocan in vessels that likely were not exposed to vascular perfusion makes this less probable.  
In addition, endocan present in the brain vasculature may provide a source for releasable 
endocan that may diffuse away and regulate other distant processes (Sarrazin et al., 2010) 
opening a new avenue for investigation.  
 
The antibodies used in this study generated against endocan have been previously shown to 
detect immunoreactivity in C57BL/6J and 129Sv mice, but not BALB/c mice (Depontieu et al, 
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2012).  In the current study, there was a lack of endocan immunoreactivity in 
C57BL/6JxS129xCBA background mice.  Clearly, strain background will be important for future 
studies examining endocan immunoreactivity.   The MEP14 monoclonal antibody used in this 
study recognizes the 6 last C-terminus amino acids, identical in human, mouse and rats 
(Depontieu et al., 2012).  This antibody was selected because it has been shown that in the 
absence or mutation of these 6 amino acids MEP14 did not recognize the peptide while other 
clones did not show this specificity.  For both strains in which immunoreactive endocan was 
seen it was globally maintained in mouse endothelial cells within the brain.  Western blots 
further confirmed the specificity of this antibody because immunoreactive endocan was 
detectable in total brain but not in the pituitary (data not shown).  A previous study showed a 
dissimilar pattern to the findings presented in this study for endocan immunoreactivity.  In 
human brain tissue endocan was localized in neurons and not neuroglia or blood vessels 
(Zhang et al., 2012).  The antibodies utilized were generated by injecting purified recombinant 
human endocan protein into BALB/c mice, and does not indicate the specificity of their antibody. 
This suggests that these recently commercially available antibodies may be useful to further 
investigating the normal and disease state expression of endocan in a variety of tissues and 
cells types.  
 
In addition to visualizing endocan immunoreactivity in numerous contexts, endocan labeling in 
brains taken from mice perfused with FITC may provide a tool to visualize newly forming blood 
vessels.  There was an unexpected immunoreactive pattern in brains following vascular 
perfusion with FITC. Initially after finding poor immunolabeling, additional sections were retested 
with new antibody lots (graciously donated by Lunginnov).  Upon further experiments it became 
clear that only brains either from the C57BL/6J xS129xCBA background or perfused with FITC 
had this appearance.  Experiments comparing FVB/N and C57BL/6J xS129xCBA with or 
without FITC perfusion confirmed these findings.  Only non-FITC perfused brains from 
 41 
C57BL/6J or FVB/N mice showed immunoreactive endocan.  A preliminary experiment 
attempted to block endocan labeling by adding FITC to the blocking step of a western blot.  
Although there was a decrease, it did not result in a total loss of labeling (data not shown).  To 
determine if FITC perfusion impacted the immunoreactivity of other proteins in endothelial cells, 
FITC brains were processed for immunoreactive PECAM.  The labeling of antibodies against 
PECAM was not altered due to FITC perfusion. Although the exact mechanism for the lack of 
endocan immunolabeling in FITC positive vasculature remains unknown, there is a strong 
potential benefit of this reliable finding. FITC labels and identifies blood vessels in which 
blood/perfusate can flow.  Only if the dye reaches the endothelial cell will they be stained. 
Endocan antibodies can recognize the proteoglycan, regardless of whether it is part of a 
functional blood vessel. Images acquired using confocal microscopy showed endocan-positive 
blood vessels connecting with FITC-positive blood vessels, with no colocalization. Therefore, 
vascular perfusion with FITC followed by examination of immunoreactive endocan may provide 
a tool for viewing nonfunctional blood vessels. 
 
Overall, immunoreactive endocan was detected abundantly in a pattern consistent with the 
majority of cerebral vasculature in the mouse brain.  At P12 and P20, C57BL/6J and FVB/N 
mice showed this distribution pattern, while immunoreactive endocan was absent in a C57BL/6J 
xS129xCBA mixed background.  Brains perfused with FITC only had endocan immunoreactivity 
where FITC was not present, perhaps indicating locations where blood vessels are not yet 
functional.  In conclusion, immunoreactive endocan provides another tool for examining cerebral 
vasculature and in the presence of FITC perfusion may also provide a tool to visualize newly 







Figure 3.1. Immunoreactive endocan was distributed throughout the mouse brain at 
postnatal day 12.  There was a global blood vessel pattern of immunoreactive endocan that is 
exemplified by images from the cortex (a. CTX), hippocampus (b), and paraventricular nucleus 















Figure 3.2. Immunoreactive endocan was distributed throughout the brain in C57BL/6J 
background mice on postnatal day 20.  There was a global blood vessel pattern of 
immunoreactive endocan that is exemplified by images from the cortex (a, d; CTX), 
hippocampus (b, e), and paraventricular nucleus of the hypothalamus (c, f; PVN). 
Immunoreactivity was not detected in the absence of primary antibodies (g). Scale bar = 100µm 








Figure 3.3. Immunoreactive endocan was distributed throughout the brain in FVB/N but 
not mixed C57BL/6J /S129/CBA background mice on postnatal day 20. There was a global 
blood vessel pattern of immunoreactive endocan in the cortex (a. CTX), hippocampus (b), and 
paraventricular nucleus of the hypothalamus (c. PVN) of FVB/N, but no immunoreactivity in 







Figure 3.4. Vascular perfusion of FITC allowed identification of cerebral vasculature, but 
blocked detection of endocan immunoreactivity. Images of FITC labeled blood vessels (a,d) 
show lack of colocalization with endocan (c,f). Immunoreactive endocan was only found in blood 
vessels devoid of FITC (b,e).  Vascular perfusion of FITC did not block detection of 
immunoreactive platelet endothelial cell adhesion molecule (i).  This procedure may reveal 
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CHAPTER 4. DEVELOPMENT OF THE BLOOD-BRAIN BARRIER WITHIN THE 






The blood-brain barrier (BBB) is a critical contributor to brain function. To understand its 
development and potential function in different brain regions, the postnatal (P) BBB was 
investigated in the mouse cortex (CTX), lateral hypothalamus (LH), and paraventricular nucleus 
of the hypothalamus (PVN). Brains were examined on postnatal days (P)12, P22 and P52 for 
BBB competency and for pericytes as key cellular components of the BBB demarcated by 
immunoreactive desmin. Glucocorticoid influences (excess dexamethasone; dex) during 
prenatal development were also assessed for their impact on the blood vessels within these 
regions postnatally.   At P12 there was significantly more extravascular leakage of a low 
molecular weight dye (fluorescein isothiocyanate) in the CTX than within hypothalamic regions. 
For pericytes, there were low levels of desmin immunoreactivity at P12 that increased with age 
for all regions. There was more desmin immunoreactivity present in the PVN at each age 
examined.  Fetal dex exposure resulted in decreased blood vessel density within the PVN at 
P20. In the CTX, dex exposure increased BBB competency, in contrast to the PVN where there 
was a decrease in BBB competency and increased pericyte presence.  Overall, unique 
alterations in the functioning of the BBB within the PVN may provide a novel mechanism for 







The vasculature of the brain differs from the periphery in several characteristics.  A key 
difference is the blood-brain barrier (BBB), which restricts access to the brain parenchyma 
through a complex network of tight junction proteins, proteoglycans, endothelial cells, basal 
lamina, vascular smooth muscle cells, pericytes and glial cells (Norsted et al. 2008).  As more 
research implicates the BBB in disease onset and progression (Gosselet et al. 2011; Daneman 
2012; Abbott & Friedman 2012), its development and function becomes a more important area 
of focus.  
 
Pericytes play a role in the development and integrity of the BBB.  Immunoreactive desmin 
provides a reliable biochemical marker of pericytes (Hellstrom et al. 1999). When pericytes are 
deficient (e.g., PDGF KO mice; Armulik et al. 2010) there is an improper astrocyte end-feet 
distribution and an increase in injected tracers present in brain parenchyma.  Neuronal 
degeneration resulting in memory impairment is preceded by pericyte loss (Bell et al. 2010). 
During disease states such as stroke, pericytes can migrate in to coordinate blood flow 
regulation, permeability of the BBB, and reestablishment of neurovascular unit (Liu et al. 2012).  
 
Although much BBB research focuses on the cerebral cortex (CTX), there is no a priori reason 
to assume that all other brain regions maintain the BBB under the same rules. For example, 
circumventricular organs maintain a more permeable BBB within the brain but vary in their 
permeability (Morita & Miyata 2012).  The current study focused on the paraventricular nucleus 
of the hypothalamus (PVN) that contains a 3-5 fold denser matrix of blood vessels than 
surrounding brain regions (Finley 1938; Ambach & Palkovits 1974; van den Pol 1982) and may 
play by different rules. The PVN houses neurons containing corticotropin-releasing hormone 
(CRH), arginine vasopressin and angiotensin that control physiological homeostasis, vasomotor 
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tone, and stress responses (Tobet et al. 2013). The vascular density arises postnatally and 
varies from rostral to caudal (Frahm et al. 2012). The greater density in the rostral and mid 
region corresponds with the general location of neuroendocrine neurons (Biag et al. 2012). 
Altering exposure of specific neurons to peripheral signals through a compromised BBB may 
contribute to various diseases and disorders (Quaegebeur et al. 2011). Within the PVN, 
decreases in BBB integrity might have effects amplified by the 3-fold greater vascular network 
(Goldstein et al. 2013). 
 
Prenatal glucocorticoid excess leads to long-term functional consequences in adulthood 
(reviewed in Harris & Seckl 2011; Tobet et al. 2013). At a cellular level, prenatal glucocorticoids 
alter glucocorticoid receptor expression in the hippocampus in adulthood (Levitt et al. 1996) and 
increase CRH levels within the PVN (Welberg et al. 2001).  Concerning the vasculature, 
prenatal glucocorticoid excess may decrease blood vessel density (Neigh et al. 2010; Vinukoda 
et al. 2010) and increase pericyte coverage (Vinukonda et al. 2010). A goal of the current study 
was to assess whether the dense blood vessel network in the PVN is impacted by fetal 
glucocorticoid excess.  
 
The current study characterized the postnatal development of the BBB and desmin-
immunoreactive pericytes in the CTX, lateral hypothalamus (LH) and PVN. Fetal exposure to 
dex resulted in enhanced BBB integrity in the CTX, while the same treatment resulted in 
decreased blood vessel density and BBB integrity within the PVN. The divergence of effect may 
be related to a selective increase in desmin-immunoreactive pericyte coverage in the PVN in 





Materials and Methods 
 
Animals 
For experiments selectively examining BBB development, the mice used were from a mixed 
C57BL6/S129/CBA background (Solomon et al. 2012) and for experiments examining the 
influence of prenatal dex mice were from an FVB/N background.  Males and females were 
combined by genotype after analysis (ANOVA sex x treatment x region at P20 p > 0.50) 
indicated no significant differences by sex.  Mice were mated overnight and the day of a visible 
plug was designated as embryonic day 0 (E0).  Pregnant dams were injected with either the 
synthetic glucocorticoid dexamethasone (0.1 mg/kg, Sigma, Inc.; Hadoke et al. 2006; O’Regan 
et al. 2004) or vehicle once daily from E11-17. The day of birth was designated P0.  For tissue 
collection, mice were anesthetized using ketamine (80 mg/kg) and xylazine (8 mg/kg) and 
transcardially perfused with heparanized PBS (pH 7.4) containing fluorescein isothiocyanate 
(FITC, Thermoscientific, MW 389.4) followed by 4% paraformaldehyde in 0.1M phosphate buffer 
(pH 7.4; modified from Miyata & Morita 2011). To examine blood vessel density, a separate 
subset of mice was anesthetized by inhaling isofluorane (Vet One) and brains were removed 
and immersion fixed with 20 ml 4% paraformaldehyde in 0.1M phosphate buffer.  For all mice, 
brains were removed, post fixed overnight, then changed into 0.1M phosphate buffer for storage 
at 4°C. Body weights were measured and sex determination was made through direct 
inspection of the gonads.  There were at least 3 separate litters combined for analysis of each 
treatment.   
 
Mice were maintained in plastic cages with aspen bedding (autoclaved Sani-chips, Harlan 
Teklad, Madison, WI, USA) in the Painter Building of Laboratory Animal Resources at Colorado 
State University. Food (#8640, Harlan Teklad, Madison, WI, USA) with filtered tap water and 
environmental enrichment provided ad libitum in a 14/10h light/dark cycle.  Animal care and 
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Tissue was processed as previously described (Frahm et. al. 2012; 2013).  Briefly, brains were 
embedded in 5% agarose and cut coronally into 50µm thick sections using a vibrating 
microtome (Leica VT1000S).  Free-floating serial sections were collected in 0.05M phosphate-
buffered saline (PBS, pH 7.4).  Excess unreacted aldehydes were neutralized in 0.1M glycine 
for 30 minutes followed by 0.5% sodium borohydride for 15 minutes.  Sections were washed in 
PBS then incubated in a blocking solution (5% normal goat serum (NGS), 0.5% Triton X-100 
(Tx), and 1% hydrogen peroxide in PBS) for at least 30 minutes.  Sections were then incubated 
in primary antiserum directed against platelet endothelial cell adhesion molecule (PECAM also 
known as CD31, 1:30; BD Biosciences, San Jose, CA) or Desmin (1:200; DAKO) in 1% BSA 
and 0.5% Tx.  For desmin, sections were processed for antigen retrieval (Dellovade et al. 2001).  
In place of the standard processing steps prior to antisera application detailed above sections 
were washed in room temperature PBS for 15 min followed by a 1 h wash in sodium citrate 
(0.05 M, pH 8.6). The sections were then placed into sodium citrate buffer preheated to 80°C for 
30 min. They were then allowed to slowly come back to room temperature (approximately 30–
35 min) after which they were returned to PBS for an additional 15 min of washes.  All sections 
were incubated for 2 nights at 4°C in primary antisera.  Sections were then washed in room 
temperature with 1% NGS and 0.02% Tx in PBS.  Sections were incubated with the appropriate 
secondary antibodies for 2h for either biotin conjugated donkey anti-rat antiserum (1:1000; 
Jackson Immunoresearch, West Grove, PA), Cy3 conjugated anti-rabbit (1:200; Jackson 
Immunoresearch) or Cy3 conjugated anti-mouse (1:200; Jackson Immunoresearch) in PBS 
containing 1% NGS and 0.32% Tx.  For PECAM, sections were incubated in a Vectastain 
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reagent (3µl/ml solutions A and B - Vectastain ABC Elite kit; Vector Laboratories, Burlingame, 
CA) at room temperature for 1 hr. After 1h of washing in Tris-buffered saline (pH 7.5), reaction 
product was developed over 5min in Tris-buffered saline containing 0.025% diaminobenzidine, 
0.02% nickel, and 0.02% hydrogen peroxide. 
 
Analysis 
For blood vessel density, images were acquired for the PVN, LH and CTX using an Olympus 
BH2 microscope with an Insight QE digital camera in Spot Advanced Software.  The section 
with the densest vascular network was selected by an investigator blind to treatment group for 
each PVN region (rostral, mid, caudal) for analysis (Frahm et al. 2012).  Image representation 
for the regions selected for analysis (CTX, PVN, and LH) is provided in Figure 4.7. 
 
Total number of blood vessel branches and length were used to characterize the density in each 
region of interest containing the PVN.  For blood vessel length, images were light corrected 
(Image J, version 1.43u) then analyzed for length using Angiogenesis Tube Formation 
(Metamorph Software, version 7.7.0.0, Molecular Devices, Inc.).  Branch points were manually 
identified and counted using Image J (cell counter). Blood vessel width was quantified by 
dividing total area by total length. For Desmin and FITC, images were acquired on a Zeiss 510-
Meta laser-scanning confocal microscope.  FITC was imaged using a 488/543 nm bandpass 
filter and emission detected using a 505/530 nm bandpass emission filter.  Cy3 for Desmin was 
imaged using a 488/543 nm bandpass filter and emission detected using a 585/615 nm 
bandpass emission filter.  Z-stacks were taken with 6 optical sections taken every 3µm obtained 
at 40x magnification using an oil immersion objective.  FITC does not remain in blood vessels 
but rather accumulates in endothelial cell nuclei (Miyata & Morita 2011).  Therefore, to view the 
vascular network within the brain we compiled Z-stacks for analysis. Extravascular leakage was 
analyzed using open-source CellProfiler (available from the Broad Institute at 
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www.cellprofiler.org).  Blood vessels were identified and a 10-pixel expansion was mapped from 
each blood vessel to create a mask to quantify leakage. This intensity was divided by FITC 
intensity within blood vessels to account for differences in perfusions. A representation of the 
CellProfiler analysis is provided in Figure 4.8.   
 
Because blood vessel density varies, final values were normalized to blood vessel area within 
the same section. For Desmin analysis, sections were measured for area of immunoreactive 
and additionally were normalized to blood vessel area using Metamorph software.  
Representative images for figures were normalized for optimal contrast in Adobe Photoshop 
(version CS for Macintosh).  Statistical significance was determined by 2-way ANOVAs: age x 
region for developmental studies and treatment x region for dex studies using SPSS software 
(version 21 for Macintosh, SPSS Inc., Chicago, IL).  In all cases region was considered as a 
repeated measure. This was followed by post-hoc comparisons based on Bonferroni correction.  





Age- and region-dependent changes in BBB competency 
The current study found changes in vasculature structure and extravascular leakage within the 
CTX, LH and PVN from P12 to P22 and P52.  These time points were chosen based on the 
significant increase in PVN angiogenesis over these ages (Frahm et al. 2012). On P12 the BBB 
in the CTX was less competent compared to the LH and PVN. There was significant 
extravascular FITC leakage within the CTX at P12 compared to the LH and PVN (Figs. 4.1a, d, 
g, j; p < 0.05).  This high level of extravascular FITC was not observed in the hypothalamic 
regions of LH and PVN at P12.  At P22, there was significantly less extravascular FITC leakage 
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in the CTX compared to P12 (Figs. 4.1b, j; p < 0.05).  There were no significant differences 
between brain regions concerning extravascular FITC leakage at P22 (Figs. 4.1b, e, h).  At P52 
the BBB appeared fully functional as extravascular FITC leakage did not change in CTX, LH, 
and PVN (Figs. 4.1c, f, I, j) compared to the same brain regions at P22 (Figs. 4.1b, e, h, j). 
These findings suggest that the BBB develops at different rates in the CTX compared to the 
hypothalamic brain regions examined.   
 
Changes in Desmin immunoreactive pericytes by age and region 
Concerning postnatal and region-specific pericyte development, results showed significantly 
greater desmin-immunoreactive pericyte coverage at P22 and P52 compared to P12 (Figs. 
4.2a-i; p < 0.01).  For different brain regions, there was significantly more desmin-
immunoreactive pericyte coverage at P12 in the PVN (Figs. 4.2g-i) compared to the LH (Figs. 
4.2d-f) and CTX (Figs. 4.2a-c).  For the CTX, there was a significant increase in desmin-
immunoreactive pericyte coverage between P12 and P22 (Figs. 4.2a, b, j, k).  At all ages 
examined the PVN had significantly more desmin-immunoreactive pericyte coverage than the 
LH and the CTX (Fig. 4.2j; p < 0.01). When blood vessel density was taken into account, the 
PVN still had significantly more desmin-immunoreactive pericyte coverage than the CTX (Fig. 
4.2k; p < 0.05).  At P52, this increase in desmin-immunoreactive pericyte coverage was due to 
the morphology of the pericytes in the PVN (Fig. 4.3c) compared to the CTX (Fig. 4.3a).  
Desmin in the adult mouse labels processes running along small diameter and encircling larger 
diameter capillaries (Hellstrom et al. 1999).  The pattern of desmin-immunoreactive pericyte 
coverage in the PVN showed a wrapping pattern around blood vessels while in the CTX more 
often it extended along the blood vessels.  There were no differences in desmin-immunoreactive 
pericyte coverage in the LH (Fig. 4.3b) compared to the CTX or PVN after 50 days of age. To 
determine if the difference in pericyte coverage coincided with the size of blood vessels, blood 
vessel width was quantified (Fig. 4.3).  Blood vessel widths were greater in the hypothalamus 
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(LH – Fig. 4.3b, PVN – Fig. 4.3c) compared to the CTX (Fig. 4.3a).  Quantification showed a 
statistically significant greater blood vessel width in the PVN (but not the LH) compared to the 
CTX (Fig. 4.3d; p < 0.05) indicating that at P52, the greater desmin-immunoreactive pericyte 
coverage in the PVN (Figs. 4.2i-k) was associated with an increase in blood vessel width (Fig. 
4.3d).  To examine if this was due to the presence of larger arterioles, antibodies against 
smooth muscle actin (SMA), a marker for smooth muscle cells that surround cerebral arteries or 
arterioles (Ladecola 2004) was examined.  SMA immunoreactivity was observed in the brain, 
however, not within the PVN (data not shown) suggesting the larger width of blood vessels 
within the PVN was not due to the presence of arterioles, although this did not rule out the 
presence of venules.  In general, desmin-positive pericyte coverage increased postnatally, 
varied between brain regions, and was related to blood vessel width.   
 
Fetal Dex exposure led to altered vascular characteristics at P20 
Blood vessels that are potentially newly formed and not yet fully functional are not identified by 
vascular perfusion with FITC (Frahm et al. 2013).  Therefore, Immunoreactive PECAM was 
utilized to visualize the more complete endothelial cell population.  PECAM revealed an overall 
13% decrease in blood vessel length in the PVN for dex-treated compared to vehicle-treated 
mice at P20 (Fig. 4.4a; p <0.01).  Offspring of dex-treated mothers had significantly less total 
blood vessel length across all regions of the PVN (Fig. 4.4b; p < 0.01), while decreased branch 
points was restricted to the rostral and mid regions compared to vehicle-treated (Fig. 4.4c; p < 
0.05). Brains perfused with FITC were also examined and dex-exposed offspring had less blood 
vessel density compared to vehicle-treated (data not shown). There were no significant 
differences in blood vessel length or branch points in the LH or CTX due to dex-treatment (data 
not shown). This indicates that prenatal exposure to dex impacts blood vessels within the PVN 
of young offspring.  
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Fetal Dex exposure led to altered BBB competency at P20 
Given that structural blood vessel characteristics were impacted in offspring of mothers treated 
with dex during gestation (Fig. 4.4), it was important to assess the state of the BBB (Fig. 4.5). 
Importantly, the impact of fetal dex exposure on later BBB competency was opposite in the CTX 
versus PVN. In the CTX, there was statistically significant 12% less extravascular FITC leakage 
in offspring from mothers treated with dex compared to those exposed to vehicle (Figs. 4.5a, d; 
p < 0.05).  This suggests there was an increase in the competency of the BBB due to dex-
treatment in the CTX. In stark contrast, the mid region of the PVN showed a statistically 
significant 17% increase in extravascular FITC leakage in dex-treated compared to vehicle-
treated offspring (Figs. 4.5c, f, g; p < 0.05). There was a strong trend for prenatally dex-treated 
mice to have an increase in extravascular FITC in the rostral PVN compared to vehicle-treated 
(data not shown; p < 0.09) with no notable differences observed in the caudal PVN.  For the LH, 
there was no change in extravascular FITC leakage in offspring from mothers either prenatally 
dex- or vehicle-treated (Fig. 4.5b, e).  Due to the possibility of maternal injection providing a 
stressful stimulus that could increase endogenous glucocorticoid levels, a comparison was 
made between offspring of vehicle-injected mothers versus offspring from mothers that were not 
injected (Fig. 4.1). There were no differences in vascular characteristics or BBB competency 
when compared to non-injected mice.  Together these findings suggest that fetal antecedent 
exposure to dex decreased the density and integrity of the blood vessels selectively within the 
PVN when examined in later life.   
 
Fetal Dex exposure led to altered pericytes at P20 
To complement and further expand on the extravascular FITC data, desmin-immunoreactive 
pericyte coverage was assessed. Prenatal dex-treatment led to a significant increase in 
immunoreactive desmin on a vascular network that was less dense at P20 (Fig. 4.6).  When 
total desmin-immunoreactivity was examined in the PVN, LH or CTX, there were no dex-
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dependent differences in any region (Figs. 4.6a-g).  However, when blood vessel density was 
taken into account, there was a significant dex-dependent increase in desmin-immunoreactive 
pericyte coverage in the mid PVN (Fig. 4.6h; p <0.01).  There were no significant differences in 
the rostral or caudal PVN due to treatment.  There were also no significant differences in the 
CTX or LH due to treatment although there was a trend of increased coverage due to dex-
treatment for all brain regions examined.  Overall, prenatal dex-treated mice increased 





Interest in the regulation of BBB function ranges from pharmaceutical perspectives for gaining 
or preventing drug access to the brain parenchyma (Abbott 2013), to questions of breakdown 
that might be antecedent to disorder (Gosselet et al. 2011; Daneman 2012; Abbott & Friedman 
2012). The current study was focused on the PVN as a unique site that gains several fold 
greater vascular density than surrounding regions over the course of postnatal development. 
The increased vasculature might make changes in BBB function in this site particularly 
important. As the PVN may be particularly important as a site susceptible to fetal antecedent 
actions of excess glucocorticoids (Tobet et al. 2013), the current study also determined whether 
excess fetal glucocorticoids could impact PVN vascular characteristics. The results highlighted 
several critical points. First, that the development of vascular and BBB characteristics differed in 
the PVN versus the CTX. Secondly, that maternal exposure to excess glucocorticoids during 
pregnancy impacted vascular and BBB characteristics in their offspring. Thirdly, fetal exposure 
to dex impacted the CTX differentially than the PVN. Finally, alterations in BBB competency 
were paralleled by changes in pericyte coverage as assessed by immunoreactive desmin in 
development and as a function of fetal dex-treatment.  
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The ability of compounds to “leak” from blood vessels clearly differs among brain regions and 
can be observed using several methods. Differences in leakage among circumventricular 
organs were shown using FITC even though all are fenestrated and lack a BBB (Morita & 
Miyata 2012).  Many BBB studies predominantly focus on the cortex for changes (e.g., 
Sadowska et al. 2009; Daneman et al. 2010; Vorbrodt et al. 2001; Ezan et al. 2012; Armulik et 
al. 2010; Bell et al. 2010) and occasionally examine the cerebellum (Sadowska et al. 2009; 
Armulik et al. 2010).  For BBB development, reports indicate cortical leakage of high molecular 
weight dyes until postnatal day 21 in rats (Utsumi et al. 2000), and postnatal day 14 in mice 
(Lossinsky et al. 1986; Volbrodt et al. 1986).  The findings presented in this study also suggest 
that differences occur between brain regions such as the CTX and nuclear groups in the 
hypothalamus (i.e., LH and PVN).  Not only were differences in BBB development observed, but 
fetal exposure to dex impacted the postnatal CTX differentially than the PVN and had little to no 
impact on the LH.  This highlights the importance of studying cells in their anatomical context.  
For example, a number of studies have examined BBB competency by injecting Evans blue 
dye, perfusing saline to flush out circulating dye, and then homogenizing tissue to measure and 
analyze residual Evans blue in the tissue of interest (e.g., Bake & Sohrabji 2004).  In the current 
study, this would have concealed differences between hypothalamic subregions.  Overall, these 
findings suggests the need for further investigations to determine region-specific BBB 
development, how factors such as excess glucocorticoids during fetal development can impact 
BBB development, and what role this may play on an organism. 
 
Prenatal glucocorticoid excess has been implicated in depression-like behaviors (Bale 2005), 
hypertension (Levitt et al. 1996), and hypothamalic-pituitary-adrenal axis dysregulation (Levy & 
Tasker 2012) in adulthood.  Concerning the vasculature, previous work revealed decreased 
blood vessel density in the hippocampus (Neigh et al. 2010) and the germinal matrix at the level 
of the mid-septal nucleus (Vinukonda et al. 2010).  In the current study, prenatal dex-treatment 
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resulted in offspring for which the entire PVN had a reduced vascular network, albeit 
predominantly in the rostral and mid regions.  Rostral and mid regions of the mouse PVN have a 
greater density of blood vessels and neurons that correspond with the general location of 
neuroendocrine neurons. By contrast, the caudal PVN is less densely vascular than rostral 
regions and houses more preautonomic neuronal populations important for sympathetic and 
parasympathetic outflow (Biag et al. 2012).  The findings in the current study indicated that the 
blood vessel density and BBB within the caudal PVN were less impacted by excess 
glucocorticoids during development than rostral and mid regions.  There were no changes 
observed in the LH or CTX.  Even though prenatal dex-treatment is “global” in access, and 
impacts can be broad (physiology and behavior), the influences in the current study were 
selective within brain compartments. 
 
The hallmark of capillaries is the ability to pass red blood cells in single file through tissues of 
the body. If red blood cells are the same size throughout, it is curious that not all capillaries in 
the brain have the same width. Nonetheless, the current results confirm a previous study in rats 
showing that capillaries of the PVN have larger lumens when compared to a region ventrolateral 
to the PVN (Van den Pol 1982).  Although this may be due to a higher presence of venules 
(Ambach & Palkovits 1974), we did not make this determination.  The results of the current 
study extended observations to mice, a comparison to CTX, and further showed that capillary 
widths were not altered due to prenatal dex-treatment even when total capillary volumes 
changed.   
 
The developmental time course for BBB proteins varies for detectability and relationship to BBB 
competency.  In previous studies in mice BBB proteins did not reach adult levels in the CTX 
until around P14 (Vorbrodt et al. 2001).  For the gap junction protein Connexin 30, 
immunoreactivity was detected in the mouse cortex beginning at postnatal P12 with the level of 
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protein comparable to adulthood identified around P15 (Ezan et al. 2012). Results in the current 
study showed higher levels of extravascular FITC leakage occurring in the CTX at P12 than at 
P22, in agreement with the proposal that the BBB is still developing postnatally. At P52, 
compared to P12 and P22, the results showed that the BBB prevented FITC from entering the 
brain parenchyma in all regions examined.  Prenatal exposure to dex impacted the BBB at P20 
with less detectable extravascular FITC leakage in the CTX.  In sheep CTX, prenatal dex 
resulted in an increase in tight junction proteins, a component of a functional BBB (Sadowska et 
al. 2009) and in agreement with the current findings.  By contrast for the PVN, fetal dex led to 
the opposite result, greater extravascular FITC leakage suggesting BBB compromise. Insults 
such as excess prenatal glucocorticoid exposure can alter permeability and integrity in a brain 
region dependent manner and for the PVN where the result is a less-dense vascular network 
that has a compromised BBB; the impact may alter physiology and behavior based on the 
neuronal population involved (Biag et al. 2012; Kádár et al. 2010; Tobet et al. 2013; Goldstein et 
al. 2013).     
  
Prior studies examining pericytes found that fetal glucocorticoids increased cell coverage of 
NG2-positive pericytes in rabbits and humans (Vinukonda et al. 2010).  While the prior report 
was in the germinal matrix for the cerebral cortex, the current study produced similar changes in 
the mid region of the PVN in mice.  For pericytes, immunoreactive desmin suggests that 
changes have occurred, but not whether the number, distribution, or size of pericytes was 
impacted. One explanation for why there is the same level of desmin-immunoreactivity in the 
PVN on fewer blood vessels due to prenatal dex-treatment may be due to recruitment and 
migration. Pericytes migrate in response to new vessel formation, traumatic stress, or under 
hypoxic injury or state (Dore-Duffy et al. 2000).  In dex-treated offspring that exhibited a 
decreased vascular network, this may be a sign of prior hypoxia with pericyte recruitment 
needed to promote recovery.  Enhanced pericyte coverage may serve to help stabilize the 
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vasculature (Vinukoda et al. 2010).  Since pericytes can regulate capillary diameter through 
constricting the vascular wall (Bell et al. 2010), differences due to prenatal glucocorticoid excess 
may impact blood flow within the PVN.  Future studies are needed to determine how changes in 
desmin-positive pericyte coverage in dex-treated offspring impacts the ability of the BBB to 
function properly as observed here through extravascular FITC leakage and whether this 
impacts neuronal function.    
 
In summary, the current study examined the postnatal development of the BBB and 
demonstrated that fetal dex exposure altered the integrity of the BBB in the PVN.  There was an 
increase in BBB permeability at P20 in the highly vascularized middle region of the PVN. 
Decreases in blood vessel density and BBB integrity within the mid (and to some extent rostral) 
regions of the PVN may impact the ability of neuroendocrine neurons (Biag et al. 2012; Kádár et 
al. 2010) to function normally.  Understanding changes in the crosstalk between neurons and 
blood vessels in the PVN may provide insight into the long-term behavioral and physiological 
consequences observed in human and animal studies when exposed to glucocorticoid excess 




Figure 4.1 Postnatal blood-brain barrier development in the mouse cortex (CTX), lateral 
hypothalamus (LH) and paraventricular nucleus of the hypothalamus (PVN) at P12, P22 
and P52.  Example confocal images for each region are provided in panels a-i, and a 
quantitative summary by graph in j. There was a significant increase in extravascular FITC 
leakage in the CTX (a) compared to the LH (d) and PVN (g) at P12 (j; p < 0.05).  Between P12 
and P22 there was a significant decrease in extravascular FITC leakage specifically in the CTX 
(a, b; p < 0.05).  At P22, there were no significant differences observed in extravascular FITC 
leakage between brain regions (b, e, h).  At P52, there were no significant differences in 
extravascular FITC leakage (c, f, i) compared to P22 or between brain regions (j).  Number of 
animals per group (n=6) is provided in the code for the bars panel j. Significant differences 




Figure 4.2 Postnatal desmin-immunopositive pericyte coverage in the mouse cortex 
(CTX), lateral hypothalamus (LH) and paraventricular nucleus of the hypothalamus (PVN) 
at P12, P22 and P52. Example confocal images for each region are provided in panels a-i, and 
a quantitative summary by graph in j and k.  There was a significant increase in desmin-
immunoreactive pericyte coverage in the PVN (g) compared to the CTX (a) and LH (d) at P12 (j, 
k; p < 0.05).  At P22 there was a significant increase in desmin-immunoreactive pericyte 
coverage in the CTX (b) and PVN (h) compared to P12 (j, k; p < 0.05).   There were no 
significant differences in any brain region between P22 and P52 for desmin-immunoreactive 
pericyte coverage (j, k).  There was an overall significant increase in desmin-positive pericyte 
coverage for the PVN at all ages (g-i) compared to the LH (d-f) and CTX (a-c) for all ages (j, k; p 
< 0.05). Number of animals per group (n=5) is provided in the code for the bars panels j and k. 
Significant differences between regions indicated by * and for age as #. Scale bar = 50µm in 












Figure 4.3 Blood vessels in the paraventricular nucleus of the hypothalamus (PVN) were 
wider than in the mouse cortex (CTX) at P12 and P52.  Higher magnification of blood vessels 
at P52 visualized with fluorescein isothiocyanate perfusion in the CTX, lateral hypothalamus 
(LH) and PVN show that desmin morphology varied between brain regions with the PVN (c) 
having more of a wrapping pattern compared to the CTX (a) and LH (b).  The wrapping may be 
related to a significantly greater blood vessel width in the PVN compared to the CTX at P12 and 
P22 (d, p < 0.05).  There were no significant differences at P22 or in the LH when compared to 
the CTX or PVN at any age. Number of animals per group (n=5) is provided in the code for the 
bars panels j and k. Significant differences between regions indicated by *. Scale bar = 20µm in 






Figure 4.4 Prenatal exposure to dexamethasone (dex) impacted blood vessel density in 
the postnatal mouse paraventricular nucleus of the hypothalamus (PVN) at P20.  There 
was a significant decrease in blood vessel length for the entire PVN for dex-treated compared to 
vehicle-treated mice (a, **p < 0.01).  There was also a region-specific significant decrease in 
blood vessel length in the rostral, mid and caudal regions of the PVN in dex-treated compared 
to vehicle-treated mice (b, ***p < 0.0001).  For branch points, there was only a significant 
decrease in the rostral and mid PVN in dex-treated compared to vehicle-treated mice (c, *p < 












Figure 4.5 Prenatal exposure to dexamethasone (dex) impacted blood-brain barrier 
development in the mouse cortex (CTX) and paraventricular nucleus of the hypothalamus 
(PVN) at P20. Example confocal images for each region are provided in panels a-f, and a 
quantitative summary by graph in g and h. In the CTX, there was a significant decrease in 
extravascular FITC leakage in dex-treated compared to vehicle-treated mice (a, d, g; p < 0.05). 
For the PVN, there was a significant increase in extravascular FITC leakage in offspring of dex-
treated compared to vehicle-treated mice in the mid region (c, f, g; p < 0.05).  There was no 
impact of fetal dex observed in the lateral hypothalamus (LH; b, e, g). Number of animals per 
group is provided in the code for the bars in panels g and h. Significant differences for treatment 










Figure 4.6 Prenatal exposure to dexamethasone (dex) impacted desmin-immunoreactive 
pericyte coverage in the mouse paraventricular nucleus of the hypothalamus (PVN) at 
P20. Example confocal images for each region are provided in panels a-f, and a quantitative 
summary by graph in g and h. In the PVN, there was a significant increase in desmin-
immunoreactive pericyte coverage in dex-treated compared to vehicle-treated mice (c, f; *p < 
0.01) when blood vessel density was taken into account (h; *p < 0.01).  There were no 
significant differences observed in desmin-immunoreactive pericyte coverage in the cortex 
(CTX; a, d) or lateral hypothalamus (LH; b, e) between dex-treated or vehicle-treated mice. 
There was a significant increase in desmin-immunoreactive pericyte coverage in the PVN 
regardless of treatment compared to the CTX and LH (g). Number of animals per group is 
provided in the code for the bars in panels g and h. Significant differences between regions 















Figure 4.7 Regions selected for analysis. Brightfield image of a coronal section 
immunolabeled for Platelet Endothelial Cell Adhesion Molecule to visualize blood vessels.  
Boxes show representative regions of the Cortex (CTX), Lateral Hypothalamus (LH), and 






Figure 4.8.  Analysis of vascular permeability. Fluorescence intensities were measured 
outside of blood vessels (i.e., leak) in the Cortex (CTX), Lateral Hypothalamus (LH) and 
Paraventricular Nucleus of the Hypothalamus (PVN). Semi-automated leakage calculations 
were made using CellProfiler software.  Blood vessels were identified in panels a-c, a 10-pixel 
expansion was mapped from each blood vessel to create a mask and intensity was measured 
as shown in panel d, and blood vessel intensity was then subtracted as in panel e to generate 
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CHAPTER 5. PRENATAL DEXAMETHASONE ALTERS THE COMPOSITION OF THE 
BLOOD-BRAIN BARRIER WITHIN THE PARAVENTRICULAR NUCLEUS OF THE 





Neurons within the paraventricular nucleus of the hypothalamus (PVN) integrate peripheral 
signals and coordinate responses that are important for maintaining homeostasis, vasomotor 
tone, energy balance, stress responses and behavioral functions.  In addition to the density of 
its cytoarchitecture, the PVN also contains 3-fold more blood vessels than surrounding brain 
regions.  Previously, exposure to excess glucocorticoids during fetal development resulted at 
postnatal day (P)20 in an increased area of desmin immunoreactive (ir) pericytes on a 
significantly smaller blood vessel network within the PVN coincident with increased blood-brain 
barrier (BBB) permeability (Frahm & Tobet, 2013abs).  To further define the temporal 
parameters of these effects, pregnant mice were exposed to vehicle (veh) or the synthetic 
glucocorticoid dexamethasone (dex; 0.1mg/kg) during embryonic days 11-17.  To determine if 
changes observed at molecular and cellular levels impacts behavior, offspring were tested for 
depressive-like behavior using a tail-suspension test (TST) after P50.  After behavior testing, 
males and females were perfused with the low molecular weight dye fluorescein isothiocyanate 
(FITC) and fixed using paraformaldehyde. Brain sections containing the PVN were examined for 
ir-GFAP+ astrocytes and ir-desmin+ pericytes. Veh-treated females had significantly more total 
ir-GFAP than dex-treated females in the PVN.  Astrocyte associations with blood vessels were 
estimated by examining GFAP-ir fluorescent overlap with FITC labeled vasculature. There was 
a similar pattern of significantly decreased ir-GFAP covering blood vessels in dex-treated 
females compared to veh-treated females.  For ir-desmin+ pericytes in the PVN, there was a 
 74 
significant increase in ir-desmin normalized to blood vessel density in dex-treated compared to 
veh-treated males.  There were no significant differences observed for dex treatment or sex in 
extravascular FITC leakage as a proxy for BBB function, or blood vessel density.  For the TST, 
male and female offspring from pregnant mice treated with dex had significantly shorter 
latencies to first bout of immobility compared to vehicles demonstrating that there are long-term 
behavioral consequences of prenatal dex exposure.  We hypothesize that these alterations in 
BBB components in combination with environmental or physiological challenges may result in 





Cardiovascular disease (CVD) is the number one cause of death worldwide (Thayer et al., 
2010).  Individuals suffering from CVD are more likely to have major depressive disorder (MDD; 
The World Health Report, 2001).  This co-morbidity constitutes an approximate 20% population 
prevalence (Reviewed in Goldstein et al., 2014), and by 2020 is postulated to be the number 
one cause of disability worldwide (The World Health Report, 2001).  To understand the etiology 
with hopes of reducing the incidence of MDD and CVD, independently and collectively, studies 
are needed to identify potential mechanisms.   
 
A key brain region involved in the comorbidity of CVD and MDD is the paraventricular nucleus of 
the hypothalamus (PVN; Baune et al., 2012; Goldstein et al., 2014).  The PVN is comprised of 
numerous neuronal phenotypes that integrate peripheral signals to regulate many important 
functions that range from initiating flight or fight responses, maintaining homeostasis, vasomotor 
tone, and energy balance (Ferguson et al., 2008; Handa & Weiser, 2013; Hill, 2012; Swanson & 
Sawchenko, 1983).  PVN neurons contain the neuropeptides corticotropin releasing hormone, 
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arginine vasopressin, oxytocin, thyrotropin-releasing hormone, somatostatin, and angiotensin 
(Armstrong et al., 1980; Biag et al., 2012; Ford-Holevinski et al., 1991; Handa & Weiser, 2013; 
Simmons & Swanson, 2009; Swanson and Sawchenko, 1983).  Receptors for gamma-
aminobutyric acid (GABA), estrogens, androgens, glucocorticoids, and angiotensin II type 1 are 
also present (Bingham et al., 2006; Fan et al., 2012; Lund et al., 2004; McClellan et al., 2010; 
Mitra et al., 2003).  Glucocorticoid signaling within the PVN has been shown to change the 
neural circuitry within the PVN resulting in dysregulation of the hypothalamic-pituitary-adrenal 
(HPA) axis, similar to the effects observed in patients with depression (Levy & Tasker, 2012).  
Interestingly, the PVN also contains neurons that attenuate hypertension (Biancardi et al., 2013; 
Braga et al., 2011; Ferguson et al., 2008; Sriramula et al., 2011).  Therefore, the PVN may 
provide a site for cell-based mechanisms that underlie the co-morbidity of CVD and MDD.   
 
In addition to its dense neuronal population, the PVN also has a high blood vessel density 
(Ambach & Palkovits, 1974; Basir 1931; Craigie, 1940; Finley, 1938; Menendez & Alvarez-Uria, 
1987; Poppi, 1928) that in the mouse develops postnatally (Frahm et al., 2012).  The highest 
density is also localized to the rostral two-thirds of the PVN (Frahm et al., 2012), which 
coincides with the sites of the majority of neuroendocrine neurons (Biag et al., 2012).  The 
role(s) of this dense vascular bed is unknown; however, it has been shown to decrease at 
postnatal day (P)20 due to either a loss of functional GABAB receptors (Frahm et al., 2012) or 
exposure to excess glucocorticoids during prenatal development (Frahm & Tobet, 2013abs).  
The ability to regulate the vascular network within the PVN suggests that changes may impact 
physiology and behavior.   
 
What sets brain blood vessels apart from their peripheral counterparts is a restrictive barrier 
referred to as the blood-brain barrier (BBB). The BBB regulates a microenvironment necessary 
for reliable neuronal signaling by protecting the brain from potentially harmful items such as 
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toxins. The BBB consists of a continuous layer of endothelial cells, which form the walls of blood 
vessels, connected to one another through tight junctions (Reviewed in Abbott et al., 2006; 
Hawkins & Davis, 2005; Iadecola, 2004; Saunders et al., 2013).  Other components include 
pericytes and astrocytic endfeet that surround endothelial cells (Hawkins & Davis, 2005). 
Changes to any of these components that together form the BBB could compromise its 
functional integrity.  
 
Recently, there has been a focus to understand the BBB in the context of communication with 
neurons.  There are coordinated interactions between neurons, astrocytes, and pericytes that 
are essential for the health and function of the central nervous system. This collection of 
anatomical partners is often referred to as neurovascular units (NVU; Hawkins & Davis, 2005).  
In adulthood, the NVU is formed by astrocytic endfeet and pericytes in close proximity to blood 
vessels (Saunders et al., 2013).  Changes in the NVU within the PVN could potentially result in 
a wide range of diseases and disorders (Quaegebeur et al., 2011).  For example, spontaneously 
hypertensive rats exhibited increased BBB permeability allowing circulating angiotensin II to 
leak into the PVN and directly alter blood pressure regulation (Biancardi et al., 2013). 
 
Increased fetal exposure to glucocorticoids can also contribute to CVD (Maccari et al., 2003; 
Baum et al., 2003; Hadoke et al., 2006) and depression-like behavior (Bale, 2005; Roque et al., 
2011).  At the cellular level, exposure to excess glucocorticoid during prenatal development 
impacts the neuronal (Levitt et al., 1996; Welberg et al., 2001) and vascular network (Frahm & 
Tobet, 2013abs) within the PVN.  Also, mice exposed to excess glucocorticoids during prenatal 
development displayed an increase in extravascular leakage of the low molecular weight dye 
FITC along with an increase in desmin-ir pericytes coverage at postnatal day (P) 20 (Frahm & 
Tobet, 2013abs).  This demonstrates changes in BBB components accompanied by a partial 
breakdown of BBB function following in response to change in glucocorticoid exposure.     
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The current study was conducted to determine the long-term impact of fetal dex exposure on 
changes in PVN NVU. Mice were exposed to excess glucocorticoids during prenatal 
development and examined at P50.  Assessment of blood vessel density, BBB competency, 
desmin-ir pericyte coverage and GFAP-ir astrocytes within the PVN at indicated that there is 
partial recovery of BBB function after puberty, but sex-dependent differences in BBB 
components during adulthood.  Both males and females displayed an increase in depression-
like behavior, indicating long-term functional consequences of fetal glucocorticoid excess.   
 
 
Materials and Methods 
 
Mice from an inbred FVB/N background were maintained in plastic cages with aspen bedding 
(autoclaved Sani-chips, Harlan Teklad, Madison, WI, USA) in the Painter Building of Laboratory 
Animal Resources at Colorado State University. Food (#8640, Harlan Teklad, Madison, WI, 
USA) with filtered tap water and environmental enrichment provided ad libitum in a 14/10h 
light/dark cycle.  Animal care and handling was in accordance with the Colorado State 
University Animal Care and Use Committee guidelines. 
 
Mice were mated overnight and the day of a visible plug was designated as embryonic day 0 
(E0).  Pregnant dams were injected with the synthetic glucocorticoid dexamethasone (dex, 0.1 
mg/kg, Sigma, Inc.; Frahm & Tobet, 2013abs; Hadoke et al. 2006; O’Regan et al. 2004) or 
vehicle (veh) once daily from E11-17. The day of birth was designated P0.  Mice were weaned 
and ear punched for identification on P19 and then left relatively undisturbed until P50 when 
they were subjected to behavior tests followed by tissue collection. Animals were handled for at 
least two days before each behavior test and were tested using the tail suspension test (TST) 
and Sucrose Preference Test (SPT).  For females, cycle stage was determined by analysis of 
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vaginal cytology (Becker et al., 2005) and testing only occurred during estrus.  Behavior tests 
occurred between 11:00 am – 3:00 pm in the light phase, was video recorded using a Sony HD 
Handicam, and analyzed by an individual blinded to treatment and sex using the Stopwatch+ 
program (Center for behavioral Neuroscience; Atlanta, GA).   
 
At least four days after the last behavior test, mice were anesthetized using ketamine (80 
mg/kg) and xylazine (8 mg/kg) and transcardially perfused with heparanized PBS (pH 7.4) 
containing fluorescein isothiocyanate (FITC, Thermoscientific, MW 389.4) followed by 4% 
paraformaldehyde in 0.1M phosphate buffer (pH 7.4; modified from Miyata & Morita, 2011).  
Brains were removed, post fixed overnight, and changed into 0.1M phosphate buffer for storage 
at 4°C.  
 
Behavior Testing 
After P50, mice were tested using the tail suspension test as previously described (Stratton, 
2012).  The TST is widely used to identify changes in depression- and helpless-like behaviors 
(Cryan et al., 2005).  Briefly, mice were suspended by their tail, to a horizontal rod with adhesive 
tape at a height of 40 cm for 6 min and behavior was recorded via camcorder.  Females were 
tested only during estrus.  At least 4 days after the TST, SPT was initiated.  SPT consisted of 
fluid intake measurement of 0.1% sucrose concentration with 2 days acclimation followed by 4 
days with a two-bottle- choice paradigm (Mueller & Bale, 2008).  Specially, mice were allowed to 
acclimate to individual housing and two bottles that were filled with water for two consecutive 
days.  The following two days bottles were changes to contain sucrose.  Days 5 – 9 mice were 
given the choice of either water or sucrose.  Bottle weights were collected during the same time 
period during the 4 testing days and switch daily.  The SPT was omitted because it was 
conducted using a subphysiological 0.1% (Alsio et al., 2011) and results would not be an 
adequate measurement of anhedonia.    
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Immunohistochemistry 
Tissue was processed as previously described (Frahm et al. 2012; 2013).  Brains were 
embedded in 5% agarose and cut coronally into 50µm thick sections using a vibrating 
microtome (Leica VT1000S).  Free-floating serial sections were collected in 0.05M phosphate-
buffered saline (PBS, pH 7.4).  Excess unreacted aldehydes were neutralized in 0.1M glycine 
for 30 minutes followed by 0.5% sodium borohydride for 15 minutes.  Sections were washed in 
PBS and incubated in a blocking solution (5% normal goat serum (NGS), 0.5% Triton X-100 
(Tx), and 1% hydrogen peroxide in PBS) for at least 30 minutes.  Sections were then incubated 
in primary antisera directed against Desmin (1:200; DAKO M0760) or GFAP (1:250; DAKO 
Z0334) in 1% BSA and 0.5% Tx.  For desmin, sections were processed for antigen retrieval 
(Dellovade et al. 2001; Frahm et al., 2013).  In place of the standard processing steps prior to 
antisera application detailed above, sections were washed in room temperature PBS for 15 min 
followed by a 1 h wash in sodium citrate (0.05 M, pH 8.6), then placed into sodium citrate buffer 
preheated to 80°C for 30 min. They were then allowed to slowly come back to room temperature 
(approximately 30–35 min) after which they were returned to PBS for an additional 15 min of 
washes.  All sections were incubated for 2 nights at 4°C in primary antisera.  Sections were then 
washed in room temperature with 1% NGS and 0.02% Tx in PBS followed by incubation with 
the appropriate secondary antibodies for 2h for using either Cy3 conjugated anti-rabbit (1:200; 
Jackson Immunoresearch 711-166-152) or Cy3 conjugated anti-mouse (1:200; Jackson 
Immunoresearch 711-165-150) in PBS containing 1% NGS and 0.32% Tx.   
 
Analysis 
Desmin, GFAP and FITC images were acquired for the PVN, LH and CTX on a Zeiss 510-Meta 
laser-scanning confocal microscope.  FITC was imaged using a 488/543 nm bandpass filter and 
emission detected using a 505/530 nm bandpass emission filter.  Cy3 for Desmin and GFAP 
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were imaged using a 488/543 nm bandpass filter and emission detected using a 585/615 nm 
bandpass emission filter.  Z-stacks were acquired with 6 optical sections taken every 3µm 
obtained at 40x magnification using an oil immersion objective.  The section with the densest 
vascular network was selected by an investigator blind to treatment group for each PVN region 
(rostral, mid, caudal) for analysis (Frahm et al. 2012).  To view the vascular network within the 
brain Z-stacks were compiled. 
 
Blood vessel density, width and extravascular leakage were determined as previously described 
(Frahm & Tobet, 2013abs).  Images were inverted (Photoshop), light corrected (ImageJ, version 
1.43u) then analyzed for length, as a measure of density, using Angiogenesis Tube Formation 
(Metamorph Software, version 7.7.0.0, Molecular Devices, Inc.).  Extravascular leakage was 
analyzed using open-source CellProfiler (available from the Broad Institute at 
www.cellprofiler.org).  Blood vessels were identified and a 10-pixel expansion was mapped from 
each blood vessel to create a mask to quantify leakage. This value was divided by FITC 
measured within blood vessels to account for differences in perfusions.  Total Desmin-ir and 
GFAP-ir was measured for area of immunoreactivity and normalized to blood vessel area using 
Metamorph software.  For GFAP-ir astrocytes in proximity to FITC labeled blood vessels, 
confocal stacks were merged and FITC-labeled blood vessels and GFAP-ir astrocytes were 
independently threshold, converted to binary, multiplied together, and areas that overlapped 
were quantified (ImageJ).  Statistical significance was determined by ANOVA as sex X 
treatment (veh vs. dex) X region as a repeated measure using SPSS software (SPSS Inc., 
Chicago, IL).  Values are reported as mean + SEM and p < 0.05 was considered significant.  
Representative images for figures were normalized for optimal contrast in Adobe Photoshop 




For the TST, times spent struggling or immobile were quantified.  Time to first bout of immobility 
was determined as an indication of depression-like and helpless-like despair behavior (Francis 





Blood vessel density was analyzed after P50 in both males and females exposed to excess 
glucocorticoids during prenatal development.  There was a significant increase in the rostral 
(figure 1a) and mid (figure 1b) PVN compared to CTX or LH (p < 0.05), consistent with previous 
studies (Frahm et al., 2012; Frahm & Tobet, 2013abs).  Within the PVN, however, there were no 
differences in offspring of dex-treated mothers when examined after P50 for blood vessel area 
(Figure 5.1).  Looking in the subregions of the PVN, there were no differences observed in the 
rostral (figure 5.1a), mid (figure 5.1b) or caudal (figure 5.1c) regions, or in the cortex or lateral 
hypothalamus due to sex or fetal treatment. These findings show that excess glucocorticoids 
during fetal development did not impact blood vessel density within the PVN in adulthood.  
 
The current study found long-term changes in desmin-ir pericytes due to prenatal dex-treatment.  
To determine if fetal exposure to excess glucocorticoids impacts post-pubertal BBB 
components, desmin-ir pericytes were examined in relation to blood vessel density.  After P50, 
there was a significant increase within the entire PVN for desmin-ir pericyte coverage in the 
male offspring of dex-treated mothers (figures 5.2d & 5.2e) compared to the males of veh-
treated mothers (figures 5.2b & 5.2e; p < 0.05).  For females at P50, there was a strong trend 
for offspring of dex-treated mothers (figures 5.2c & 5.2e) to have less desmin-ir pericyte 
coverage compared to veh-treated (figures 5.2a & 5.2e).  The results suggest that long-term 
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changes in BBB components due to prenatal excess glucocorticoid exposure are dependent 
upon sex.   
 
Astrocytes are another component of the BBB that were examined for long-term changes due to 
prenatal excess glucocorticoid exposure after P50.  Total GFAP-ir was examined as a marker 
for astrocytes.  There was a significant decrease in GFAP-ir within the entire PVN in the female 
offspring of dex-treated mothers (figures 5.3c & 5.3e) compared to female offspring of veh-
treated mothers (figure 5.3a & 5.3e; p < 0.05).  In addition, there was a trend for male offspring 
of veh-treated mothers (figures 5.3b & 5.3e) to have significantly less GFAP-ir than female 
offspring of veh-treated mothers (figures 5.3d & 5.3e).  These results suggest that excess 
glucocorticoids during prenatal development may lead to decreased GFAP-ir astrocytes in 
young adult females. 
 
Astrocytes serve many roles within the brain including their end-feet attachment to blood 
vessels as part of the BBB. GFAP-ir was quantified when there was optical overlap with blood 
vessels as a measure of astrocytes in proximity to blood vessels.  There was a significant 
difference in GFAP-ir covering blood vessels within female offspring of dex-treated mothers 
(figures 5.4c, 5.4g, 5.4m) when compared to female offspring of veh-treated mothers within the 
mid region of the PVN (figure 5.4a, 5.4e, 5.4m; p < 0.05).  There was also a significant decrease 
in GFAP-ir covering blood vessels in male offspring of veh-treated mothers (figure 5.4b, 5.4f, 
5.4m) compared to female offspring of veh-treated mothers in the mid region of the PVN (figures 
5.4a, 5.4e, 5.4m; p < 0.05).  Differences observed in GFAP-ir overlapping blood vessels are 
also present with higher magnification (figures 5.4i-l).  Results demonstrate that sex and excess 
prenatal glucocorticoid exposure impacted astrocytic end-feet coverage of blood vessels within 
the mid, most dense vascular region of the PVN (Frahm et al., 2012).   
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BBB competency was investigated by quantifying extravascular FITC dye leakage to determine 
if there are long-term changes to BBB competency within the PVN.  Despite the alterations in 
BBB components, there were no differences in dye leakage observed due to sex or treatment in 
the CTX (figure 5.5a), LH (figure 5.5b) or PVN (figure 5.5c) at P50.  
 
To test for long-term behavioral consequences of excess glucocorticoids during prenatal 
development, male and female offspring were assessed using the TST.  There was a significant 
decrease in the time until the first bout of immobility in male and female offspring from dex-
treated mothers compared to veh-treated (figure 5.6; p < 0.05).  Thus excess glucocorticoids 
during fetal development resulted in an increase in helplessness- and depression-like behaviors 





The PVN has been known for some time to have a dense vascular network (Ambach & 
Palkovits, 1974; Basir 1931; Craigie, 1940; Finley, 1938; Frahm et al., 2012; Menendez & 
Alvarez-Uria, 1987; Poppi, 1928), but only recently have regulated changes been studied and 
observed (Biancardi et al., 2013; Cortes-Sol et al. 2013; Frahm & Tobet, 2013abs).  The current 
study expands on alterations within the PVN vasculature by examining long-term consequences 
in adult offspring of dex-treated mothers.  Results demonstrated an increase in desmin-ir 
pericyte coverage in male offspring of mice exposed to excess glucocorticoids.  Female 
offspring of dex-treated mothers had a decrease in GFAP-ir astrocytes and a decrease in 
GFAP-ir astrocytes in proximity to blood vessels selectively within the PVN.  In addition, both 
male and female offspring of dex-treated mothers had increased depressive-like behavior. This 
study provides another example of a long-lasting consequence of fetal dex-treatments on 
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behavior of offspring, and a novel view of simultaneous impact on components of the BBB 
within the PVN in a sex dependent manner. 
 
There are a limited number of studies that examine changes in brain vasculature due to fetal 
exposure to excess glucocorticoids (Frahm & Tobet, 2012abs; Neigh et al., 2010).  Prenatal dex 
administration reduced the vasculature within the Ca3 region of the hippocampus in adult 
males, which was further attenuated by restraint stress (Neigh et al., 2010).  Interestingly within 
the basolateral amygdala, dex-treatment initially did not alter the vascular density, but after 
chronic stress there was a significant reduction (Neigh et al., 2010).  Within the PVN, a 
decrease in the blood vessel density was observed in prepubertal males and females following 
fetal exposure to dex (Frahm & Tobet, 2012abs).  In the current study, mice were examined 
after P50 (after puberty and in early adulthood) and blood vessel densities in the PVN were 
similar in offspring from veh- and dex-exposed mothers.  These findings show changes in blood 
vessel density within the brain can be age, region, and activity-dependent.  Further studies are 
needed to determine the direct impact of this diverse regulation on physiology and behavior.   
 
Much work on blood vessels or the BBB focus on the cerebral cortex (Sadowska et al. 2009; 
Vorbrodt et al. 2001; Ezan et al. 2012; Armulik et al. 2010; Bell et al. 2010).  Given the 3-fold 
greater density of vasculature in the PVN, there is significant need to determine the impact of 
stress responses and homeostasis in this region.  For example, spontaneously hypertensive 
rats have a breakdown of the BBB within the PVN causing a feed forward loop increasing blood 
pressure (Biancardi et al., 2013).  In the current study, the increase in desmin-ir pericytes in 
males and decreased GFAP-ir astrocytes in females observed in offspring of dex-treated 
mothers leads us to hypothesize that the BBB may be more susceptible to breakdown in the 
PVN during a disease state such as hypertension.   
 
 85 
Pericytes stabilize vasculature (Vinukoda et al. 2010) and regulate capillary diameter through 
constricting vascular walls (Bell et al. 2010; Hall et al., 2014).  In the current study, adult male 
offspring of dex-treated mothers had increased desmin-ir pericytes within the PVN.  Previously, 
prepubertal males and females had an increase in pericytes coverage due to excess fetal 
glucocorticoids within the PVN (Frahm & Tobet, 2012abs).  Differences due to prenatal 
glucocorticoid excess may impact blood flow within the PVN in males in adulthood, which has 
been shown to modulate metabolic exchange between capillaries and the parenchyma 
(Villringer & Dimagi, 1995).  Within the PVN, changes in capillary diameter have been proposed 
to change blood flow (Cortes-Sol et al., 2013), although real measurements are really needed.       
 
Astrocytic endfeet are an important component for a functional BBB.  Astrocytes covering 
endothelial cells regulate water influx and efflux through aquaporin 4 (AQP4) that is distributed 
throughout the brain (Alvarez et al., 2013; Haj-Yasein et al., 2011; Nico & Ribatti, 2012).  The 
observation that female offspring from dex-treated mothers had decreased GFAP-ir astrocytes 
in proximity to blood vessels may reduce AQP4 and alter water balance within the PVN.  In 
addition, certain endothelial transporters such as P-glycoprotein (P-gp) or the glucose 
transporter GLUT-1 are present in perivascular glial end-feet and alterations could change BBB 
regulation of glucose and other metabolites (reviewed in Nico & Ribatti, 2012).  Studies have 
directly shown glucocorticoids impact levels of PgP during late but not early gestation in the 
entire brain (Petropoulos et al., 2010), but whether these changes occur specifically within the 
PVN or last into adulthood are still unknown. 
 
Changes in BBB components can impact its function. Loss of the gap junction proteins (i.e., 
connexins) specifically in astrocytes weaken the BBB, allowing circulating factors to gain access 
during increased hydrostatic vascular presser and shear stress (Ezan et al., 2012).  Under 
normal conditions, there is a lack of extravascular FITC leakage (e.g., figure 2), but mice 
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exposed to excess glucocorticoids during prenatal development may have an opening of the 
PVN BBB during an increase in blood pressure or flow.  The loss of GFAP-ir astrocytes in 
proximity to blood vessels in male offspring or the increase in desmin-ir pericyte coverage in 
female offspring of dex-treated mothers may indicate loci of disorder susceptibility under certain 
conditions that decrease BBB function and integrity within the PVN.      
  
In agreement with a number of prior studies (Roque et al., 2011; Bale, 2005) these results 
provide further evidence of long-lasting behavioral consequences due to excess glucocorticoids 
during prenatal development.  A decrease in first bout to immobility demonstrates excess 
glucocorticoids during embryonic days 11-17 increased depression-like behavior in adulthood.  
Previously, prenatal dex has been shown to increase anxiolytic-like (Hossain et al., 2008) and 
depressive-like behaviors in adulthood (Roque et al., 2011).  The results presented in this study 
show a similar increase in depression-like behaviors as well as changes in BBB components 
within the PVN.  Whether other brain regions were impacted by global dex administration and 
may play a role in the observed increase in depression-like behavior in unknown.  In addition, 
what role dex treatment has on pregnant females that may directly or indirectly impact offspring 
in utero or during postnatal maternal care is unknown.   
 
The current study was conducted to test the hypothesis that exposure to excess glucocorticoids 
during prenatal development has long term impact on the vasculature within the PVN and also 
has behavioral consequences that are commensurate with alterations in the HPA axis.  The 
results indicate that maternal treatment with excess glucocorticoids (dex) lead to site selective 
(i.e., within the PVN) changes in components of the BBB in a sex-dependent manner in 
adulthood.  An increase in displayed depression-like behavior was also observed.  Therefore, 
there are long-lasting consequences on the BBB within the PVN and behavior in offspring of 
dex-treated mothers and potentially of all fetuses exposed to excess glucocorticoid stimulation 
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whether by exogenous (e.g., dex injection as per this study) or endogenous (e.g., maternal 





Figure 5.1. Prenatal exposure to dexamethasone (dex) does not impact blood vessel 
density within mouse paraventricular nucleus of the hypothalamus (PVN) at P50. The 
Rostral and Mid PVN has significantly more BV area that the CTX or LH.  There were no 





Figure 5.2. Prenatal exposure to dexamethasone (dex) impacted desmin-immunoreactive 
pericyte coverage in the male mouse paraventricular nucleus of the hypothalamus (PVN) 
at P50.  There was a significant increase in total desmin-ir in dex-treated males (d) compared to 
veh-treated males (b; p < 0.05).  There were differences observed for veh-treated (a) or dex-
















Figure 5.3. Prenatal exposure to dexamethasone (dex) impacted total GFAP-
immunoreactive astrocytes in the female mouse paraventricular nucleus of the 
hypothalamus (PVN) at P50. There was a significant decrease on total GFAP-ir in the mid 



















Figure 5.4. Prenatal exposure to dexamethasone (dex) impacted ir-GFAP surrounding 
blood vessels in the female mouse paraventricular nucleus of the hypothalamus (PVN) at 
P50. There was significantly more ir-GFAP in proximity to blood vessels in veh-treated females 
(a, e, I, m) compared to veh-treated males (b, f, j, m; p < 0.05) and dex-treated females (c, g, k, 
m; p < 0.05). 
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Figure 5.5. Prenatal exposure to dexamethasone (dex) does not impact the blood-brain 
barrier development in the mouse paraventricular nucleus (PVN) at P50.  There were no 
differences observed in the rostral, mid or caudal regions of the PVN or in the lateral 




Figure 5.6. Testing for depression-like behavior using the tail suspension test (TST).  
Results showed dex-treated males had a significantly decrease latency until their first display of 
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CHAPTER 6: DISCUSSION 
 
The current set of studies establishes that the dense vascular network within the PVN develops 
postnatally in mice.  Within the PVN, the blood vessels were selectively densest in the rostral 
and mid regions of the nucleus. Capillaries of the PVN were of larger diameters compared to 
other brain regions. The vascular network of the PVN can be regulated by both endogenous and 
exogenous factors. In mice lacking a functional GABAB receptor blood vessel density was 
decreased in in the mid region at P20. Maternal treatment with exogenous glucocorticoids 
resulted in offspring that at P20 had decreased blood vessel density, and increased 
extravascular FITC leakage and desmin-ir pericyte coverage.  In an independent replication of 
the fetal glucocorticoid treatment that examined offspring PVN vasculature after puberty there 
were sex-dependent alterations of blood brain barrier components, but no steady state 
differences in vascular density or extravascular FITC leakage. Overall, these findings 
demonstrate that GABAergic stimulation and glucocorticoid receptor activation during fetal 
development provide examples of regulatory targets for the development of the uniquely dense 
vasculature of the PVN.  
 
There is a growing body of evidence showing that nonneuronal cells are critical for brain 
development and degeneration.  Astrocytes were previously thought to be “brain glue” or simply 
support cells (Reviewed in Freeman & Rowitch, 2013; Ransom et al., 2003).  Now, it is apparent 
that they enhance neuronal function and play important roles in neurological diseases.  
Progress has been made in advancing the role astrocytes play on neuron development and 
function (Clark & Barres, 2013; del Puerto et al., 2013; Freeman & Rowitch, 2013; Ransom et 
al., 2003), but there is still work to be done on their role in NVUs and the BBB.  Data from 
clinical studies show a reduction in the total number of GFAP-ir astrocytes and astrocytic 
endfeet coverage of blood vessels in patients diagnosed with MDD (Rajkowska et al., 2013).  In 
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female offspring of dex-treated mothers I observed a decrease in total ir-GFAP and in ir-GFAP 
proximal to blood vessels within the PVN.  This suggests a mechanism for how excess 
glucocorticoids during prenatal development could predispose an individual to developing a 
disorder such as MDD in adulthood (Wyrwoll & Holmes, 2012).  The potential role a decrease in 
PVN astrocyte coverage specifically may exert on the physiology and behavior of an organism 
is still unknown.   
 
Vascular coverage by pericytes increased due to excess glucocorticoids during fetal 
development in the germinal matrix of rabbits and humans (Vinukonda et al. 2010).  I found an 
increase at P20 in both dex-treated males and females, but at P50 this increase was limited to 
dex-treated males.  It is possible that at P20 pericytes migrated into the PVN in response to new 
vessel formation, traumatic stress, or other hypoxic injury or state (Dore-Duffy et al. 2000) 
indicated by excess FITC leakage within the PVN.  At P50, enhanced pericyte coverage may 
stabilize the vasculature (Vinukoda et al. 2010).  Since pericytes can regulate capillary diameter 
through constricting the vascular wall (Bell et al. 2010), increases at both P20 and P50 due to 
prenatal glucocorticoid excess may impact blood flow within the PVN and subsequently the 
health of the neuronal population.  
 
The physiological role for the postnatal increase in blood vessel density remains elusive.  Many 
studies have characterized the dramatic blood vessel density within the adult PVN (e.g. Ambach 
& Palkovits, 1974; Basir 1931; Craigie, 1940; Poppi, 1928; van den Pol, 1997).  In rats, this 
increase occurs on the day of birth and decrease by P2, and then increases again over the next 
few weeks (Menendez & Alvarez-Uria, 1987).  Notably I observed at birth the blood vessel 
network is similar to surrounding brain regions.  By P8 there is a significant increase in blood 
vessel density.  This suggests the factors responsible for the postnatal angiogenic period in 
mice may be delayed or different than rats.  It has been hypothesized that the vast blood vessel 
 101 
network of the PVN may be used to detect plasma osmotic pressure by magnocellular neurons 
(Badaut et al., 2000) that are abundant in the mid PVN region in mice (Biag et al., 2012).  A 
decrease in PVN vasculature may reduce accessibility to oxygen and nutrients, which could 
impact a neuron’s ability to effectively relay its metabolic needs (Quaegebeur et al., 2011) or 
receive proper feedback resulting in dysfunction.  Since the mid region of the mouse PVN 
houses the majority of CRH, OT, AVP, TRH and somatostatin neurons as compared to the 
rostral or caudal regions (Biag et al., 2012), changes in vascular characteristics may alter their 
ability to respond properly to signals from the periphery.  Future studies should attempt to 
identify the factor(s) involved in the postnatal angiogenic period and if inhibition disrupts 
physiology and behavior. 
 
GABABR1 deficient mice were used to show disruptions of development for neuronal 
populations within the PVN (McClellan et al., 2010; Stratton et al., 2011).  I observed these mice 
also displayed reduced vasculature at P20 (Frahm et al., 2012).  The mechanisms responsible 
for this decrease in blood vessel development remain unclear.  These findings are consistent 
with the hypothesis that the disruption of cell placement has a direct impact on the postnatal 
angiogenic period.  Whether the phenotypes previously characterized in these mice can be 
directly tied to changes in blood vessel density remain to be determined.  Examining the 
development of the PVN from neuronal to vascular will provide insight into function as well as 
help delineate the loci of dysfunction.  
 
As the blood vessel density increases during postnatal development, so do the components of 
the BBB, maintaining its integrity.  Desmin-ir pericytes significantly increased within the PVN 
between P12 and P22.  For BBB competency, perfusion with FITC at P12 and P22 did not result 
in extravascular dye leakage.  Future studies should delineate developmental timing for BBB 
components (e.g. pericytes and astrocytes as well as particular proteins components).  The 
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timing of BBB component development can then be related to BBB functional development.  
This can be examined through FITC perfusion followed by ir-endocan.  Chapter 3 indicates that 
prior perfusion with FITC blocks endocan immunoreactivity and can be used to identify non-
functional, developing blood vessels during the postnatal angiogenic period (Frahm et al, 2013).       
 
In response to a global treatment, most observed changes were restricted to the PVN. This 
suggests the BBB varies at the individual endothelial cell level (Saubamea et al., 2012).  In fact, 
endothelial cells in the heart respond differently in the myocardium than the brain when exposed 
to glucocorticoids (Forster et al., 2006).  Differences in responsiveness to glucocorticoids in 
cultured brain endothelial cells have been observed depending on the days of embryonic 
collection (Iqbal et al., 2011).  In addition, it has been shown that excess glucocorticoids during 
prenatal development in female rats resulted in changes in vascular responsiveness in different 
blood vessels in adulthood.  Specifically, dex-treated females were less responsive to 
angiotensin II in the aorta while the mesenteric arteries when exposed to norepinephrine, 
vasopressin and potassium were more responsive (Hadoke et al., 2006).  In my studies within 
the PVN there was a loss of blood vessel density that did not occur in the LH or CTX.  
Therefore, future studies should focus on looking at specific brain regions for changes due to 
excess glucocorticoids. 
 
In seeking to identify potential angiogenic markers to further characterize the postnatal 
angiogenic period within the PVN we observed that ir-endocan was present uniformly 
throughout the brain in certain mouse strains.  This suggests that unlike the periphery, endocan 
is not a suitable marker for angiogenesis within the brain.  Endocan in the periphery and 
elevated levels in serum have been proposed to be a biomarker for cancer and sepsis (Lee et 
al., 2014; Sarrazin et al., 2006).  Recently, it was suggested that administering neutralizing 
endocan antibodies to reduce serum endocan levels may provide a therapeutic treatment for 
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sepsis in vivo (Lee et al., 2014).  Therefore, it may be useful to determine the role that endocan 
plays in brain vasculature brain before inhibiting it globally.   
 
The presence of extravascular FITC leakage and decrease in blood vessel density in offspring 
exposed to excess glucocorticoids during prenatal development only at P20 and not in a 
separate cohort at P50 indicates a potential delay in the postnatal angiogenic period within the 
PVN.  In addition, the increased presence of pericytes may indicate they were recruited to aid in 
the postnatal development of the BBB within the PVN.  Further support is shown by a functional 
BBB and normal blood vessel density within dex-treated mice during adulthood.  The exact 
cause of BBB disruption in dex-treated mice at P20 is currently unknown.  Other BBB 
components, such as tight junction proteins, do play a role and should be examined.  Prenatal 
dex increases certain tight junction proteins in the sheep cortex when looking during gestation at 
the cerebral cortex (Malaeb et al., 2007; Sadowska et al., 2009) or in vitro (Burek & Forster, 
2009; Forster et al., 2005; Romero et al., 2003).  It is possible there is a decrease at P20 in tight 
junctional proteins, consequently reducing the integrity of the BBB and permitting FITC to leak 
into the PVN in dex-treated mice.   Preliminary studies to examine tight junctions proteins Z01 
and claudin 5 by immunohistochemistry were not successful due to reagent failures. In situ 
hybridization experiments localized claudin 5 mRNA densely within the postnatal PVN (Zhang & 
Tobet, unpublished findings), but this was not examined relative to fetal dex exposure. 
 
BBB breakdown can be problematic due to disruption of the highly regulated microenvironment 
and the protection from circulating toxins (Erickson et al., 2012). During hypertension, circulating 
angiotensin II gains access to the PVN and its receptor AT1 due to BBB breakdown (Biancardi 
et al., 2013).  Therefore, circulating factors may gain access with physiological consequences.  
In the case of angiotensin II, binding to AT1 contributes to sympathetic outflow and increased 
blood pressure during hypertension (Biancardi et al., 2013).  In addition, during BBB breakdown 
 104 
it is possible for other circulating factors, which are normally regulated by transport across the 
BBB into the PVN, to have free access to their receptors.  It has been shown that increases 
transmission of vasopressin from the PVN can increase blood pressure and heart rate (Kc et al., 
2010).  Therefore, loss of BBB competency can allow circulating factors to penetrate the PVN 
and have negative consequences.   
 
In vitro models may provide important venues for future studies. Organotypic brain slices may 
be used to determine whether excess glucocorticoids or GABAB receptor antagonists such as 
CGP 55845 impact angiogenesis and components of the BBB and neurovascular unit within the 
PVN in real time.  The neuronal population may be initially impacted, then when the postnatal 
angiogenic period initiates it varies due to differences in the placement of neurons.  Since 
differences in desmin-ir pericytes varied at P20 and P50 in dex-treated mice, and blood vessel 
density was decreased in both GABAB KO and dex-treated mice, it suggests that the blood 
vessels and BBB respond to disruptions in the neuronal population.  BBB components and 
blood vessels may respond simultaneously and the use of organotypic slices may delineate this. 
The benefit of in vitro studies is the ability to control variables.  While in vitro studies have 
potential drawbacks such as the absence of blood flow and consequent shear stresses that 
affect the properties of endothelial cells (Warboys et al., 2010), studies have shown that blood 
vessels and neurons can persist in these conditions (Moser et al., 2003). I was able to maintain 
blood vessels up to 3 days in vitro and capture video sequences using Tie2-GFP mice of 
increased GFP-positive endothelial cells (figure 6.1).  Unfortunately, the paradigm was 
unreliable and improvements are still needed.  The benefits of an in vitro system to study blood 





Fig 6.1. Blood vessels maintained in vitro. Top left: Fluorecent vessels in the PVN in an adult 
fixed Tie2-GFP mouse. Provided by MJ Schow. Top right: 20x image of BVs in a P12 slice after 
2 days in vitro. Bottom left: image was taken live from a slice from Tie-2-GFP mouse in vitro for 




There is mounting evidence that BBB disruption is associated with neurological disorders.  
Initially it was assumed that BBB disruption was secondary to neuronal loss.  A prime example 
is the amyloid cascade hypothesis, which states that amyloid- peptide deposits in the brain 
initiate Alzheimer’s disease (Erickson & Banks, 2013).  Much research today focuses on this 
hypothesis; however, evidence supports looking at the BBB at its role upstream of amyloid.  
This shift in focus has extended beyond Alzheimer’s disease to other neurological disorders, 
suggesting BBB disruption proceeds and can accelerate degeneration in adulthood and aging 
(Zlokovic, 2008).  For PVN development, these studies show excess glucocorticoids or a loss of 
GABAB receptors directly or indirectly change the vascular network.  Whether there is a 
propensity for BBB breakdown to occur during aging is an area for future study.   
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In summary, this work shows a postnatal angiogenic period with the greatest increase in blood 
vessel density occurring in the rostral and mid regions of the mouse PVN.  This was disrupted at 
P20 in mice either deficient in GABAB signaling or exposed to excess glucocorticoids during 
fetal development.  Excess fetal glucocorticoids also decreased BBB competency at P20 and 
increased desmin-ir pericyte coverage.  Into adulthood, there were long lasting impacts in BBB 
components in a sex-dependent manner.  These changes observed within the neurovascular 
unit, specifically within the PVN in GABABR1 KO or dex-treated mice, may be an important 
locus for understanding disorders of the HPA axis with potential impact for mood disorders and 











Figure 6.2. Current model of postnatal blood vessel development in the paraventricular 
nucleus of the hypothalamus (PVN) along with alterations due to excess glucocorticoids 
during embryonic development.  In the mouse PVN, there is a 40% increase in blood vessel 
density between postnatal (P) days 12 and 20 and is maintained out into adulthood (A).  Excess 
glucocorticoid during prenatal development does not disturb the initial vascular network in the 
PVN but at P20 there is a decreased vascular network that has a compromised blood-brain 
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